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ABSTRACT OF THE DISSERTATION
DNA BASE EXCISION REPAIR MODULATES DNA REPEAT INSTABILITY AND
NON-B FORM DNA STRUCTURES
by
Eduardo E. Laverde
Florida International University, 2020
Miami, Florida
Professor Yuan Liu, Major Professor
The human genome is constantly attacked by endogenous and exogenous
sources of DNA damage that generates DNA base lesions and strand breaks
leading to genome instability, cell death, and diseases. To combat these adverse
effects, cells have evolved a robust DNA repair mechanism called “the DNA base
excision repair (BER),” which efficiently removes DNA lesions maintaining genome
stability. However, its underlying molecular mechanisms remain to be elucidated.
In my dissertation research, I explored the molecular mechanism by which BER
modulates trinucleotide repeats (TNR) by processing non-B form structures such
as hairpins and R-loops through the coordination among BER enzymes and
cofactors and the proteins from other DNA repair pathways. For the first time, we
discovered that Fanconi anemia-associated nuclease 1 (FAN1) coordinated with a
key BER enzyme, flap endonuclease 1 (FEN1), to prevent repeat expansion by
promoting CAG repeat deletion during BER of oxidative DNA damage. We further
demonstrated that the BER cofactor, PCNA/ubPCNA, coordinated with FAN1 to

vii

attenuate CAG repeat expansion during BER in a CAG repeat hairpin. Exploring
the mechanisms by which BER regulates TNR instability by processing bulky nonB form structures, R-loops. We found that an abasic lesion on the non-template
strand of a CAG repeat R-loop was incised by AP endonuclease 1 (APE1),
converting the R-loop into a double-flap intermediate containing an RNA:DNA
hybrid. The R-loop intermediate inhibited DNA polymerase β (pol β) DNA synthesis
and stimulated FEN1 cleavage of the repeats leading to repeat deletion. We
showed that FEN1 partially cleaved the RNA strand on a CAG repeat R-loop to
facilitate pol β skip-over of a hairpin leading to repeat deletion. We further identified
a new role of FEN1 of resolving R-loops through the BER pathway. We found that
FEN1 efficiently cleaved RNA during the processing of DNA lagging strand and Rloops and demonstrated that FEN1 also used its flap tracking to track down to the
DNA region to make a cleavage removing the RNA leading to the lagging strand
maturation and R-loop resolution via BER. Our study provides new insights into
the molecular mechanism by which BER maintains genome stability and integrity.
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INTRODUCTION
A. DNA damage and repair
The genetic information of all living creatures is encoded in long chains of
deoxyribonucleic acid (DNA) sequences that form the genome. The genetic
information is frequently passed through generations in a semi-conserved manner.
Thus, the stability of the genome is crucial for the preservation of the species.
Beneficial modifications in the genome facilitate the survival of organisms and their
adaptation to the environment and are the driving force of evolution. However,
deleterious alterations of the genome can lead to the death of organisms.
Countless modifications in our genome are the product of DNA insults generated
from endogenous or exogenous sources of DNA damaging agents, such as
reactive oxygen species (ROS) from cellular respiration, metabolic processes,
inflammatory response, environmental toxicants, among others. Most of DNA
damage is caused by the simple, spontaneous hydrolysis of DNA bases. i.e., the
hydrolysis of the N-glycosidic bond of purines, adenine (A) and guanine (G), called
depurination [3] (Fig. I.1). Depurination is the simplest DNA damage frequently
generated under physiological conditions (acid/base catalysis). It is estimated that
about 10,000 DNA purine bases are hydrolyzed per cell per day [7]. Moreover,
spontaneous deamination of cytosines (C) and 5-methylcytosine (5-meC) that can
convert the bases to uracil (U) and thymine (T), also frequently occurs under
physiological conditions [8]. The mechanism of this conversion is the direct
deamination by alkali-catalyzed hydrolysis and the nucleophilic attack by water on
the protonated base in an acid-catalyzed reaction [9]. Cytosine deamination occurs
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at a significant rate under physiological conditions. However, it is less frequent
than depurination [10]. A damage-specific DNA glycosylase subsequently
recognizes the DNA damage and ultimately repaired by DNA base excision repair
(BER) [3].

Figure I.1 DNA structures and hydrolytic attacks on DNA bases and sugars [3].

In many organisms, the majority of DNA base lesions arise from oxidative
stress generated under normal cellular processes. The DNA molecule is
susceptible to spontaneous depurination and depyrimidination via the attack by
oxygen radicals during mitochondria cellular respiration during which mitochondrial
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oxidative phosphorylation leads to the production of ATP, while it can give rise
ROS such as hydrogen peroxides (H2O2), superoxide anion radicals (O2־, hydroxyl
radicals (•OH), lipid peroxides (ROOH), peroxyl radicals (ROO•) among others
[11]. Currently, over 100 DNA modifications resulting from oxidative DNA damage
have been identified as being caused by endogenous or exogenous sources of
DNA damage [12]. The most common form of oxidative DNA damage created by
ROS is 8-oxoguanine (8-oxoG). Reactive oxygen species can also create other
types of DNA base lesions such as thymine glycol, N-substituted ureas, and
hydantoins. In addition, ROS can induce lipid peroxidation and cause exocyclic
adducts on DNA bases [13, 14]. Hydroxyl radicals can also result in bulky DNA
base damage such as cyclopurines and interstrand crosslinks, which hinders DNA
replication causing mutations during the repair [15, 16]. Furthermore, normal
cellular metabolic intermediates such as S-adenosylmethionine (SAM) can result
in alkylated DNA base damage. S-adenosylmethionine is a methyl group donor
used as a cofactor in many cellular functions, including amino acid metabolism,
RNA and DNA methylation, histone methylation, and immune response [17, 18].
S-adenosylmethionine can also donate its methyl group to DNA bases in the
absence of methyltransferases leading to the alkylation of DNA bases. Specifically,
SAM can cause N7-methylguanine (N7-mG), N3-methyl adenine (N3-mA), and O6methyl guanine (O6-mG) [19]. N3-methyl adenine can inhibit RNA and DNA
polymerases leading to genotoxic effects. 8-oxoguanine is highly mutagenic
because it can base pair with adenines instead of cytosines during DNA replication
and repair [20]. N7-methylguanine is not mutagenic but can generate single-strand
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DNA (ssDNA) breaks [21]. On the other hand, O6-mG is mutagenic because it can
base pair with thymine rather than cytosine residues [22]. N7-methylguanine and
N3-mA can be recognized by DNA glycosylase and go through BER [23].
Environmental factors are the major sources of exogenous DNA damage,
which can cause ssDNA, double-strand DNA (dsDNA) breaks, nucleotide
misincorporation, DNA adducts, and DNA crosslinks. Multiple sources that can
induce alkylating DNA base damage include anticancer drugs, plant byproducts,
and antiseptic chemicals, including methyl methanesulfonate (MMS) and Nmethyl-N′-nitro-N-nitrosoguanidine (MNNG), temozolomide, methylazoxymethanol
(MAM), β-propionolactone, among others [24]. These types of alkylating DNA
damaging agents can create N7-mG, N3-mA, as well as O6-mG [24]. It has been
shown that MMS alkylation is 20,000 folds higher than from endogenous SAM
reactivity [25]. Ultraviolet radiation (UVR) is another source of environmentallyinduced DNA damage [26]. For instance, UV-A can generate singlet oxygen (1O2),
which can indirectly photosensitize DNA bases and induce ssDNA breaks. [27].
Conversely, UV-B radiation can promote chemical modification in DNA bases and
cause the formation of complex DNA damage such as pyrimidine dimers, which
are recognized and repaired by NER. These DNA base lesions can result in
nucleotide misincorporation during replication and repair [8]. Also, tobacco smoke
can result in the formation of bulky DNA adducts such as O4-POB-dT and O2-POBdT that are subjected to repair by NER [28].
Failure to repair DNA base lesion can result in DNA replication errors
leading to genome instability, mutations, and cell death. Damage to the DNA can
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cause nucleotide misincorporation by DNA polymerases or DNA sequence
misalignment during DNA replication and repair. High levels of oxidative or
alkylating DNA damage can cause accumulation of ssDNA breaks, ultimately
leading the formation of a double-strand break, chromosomal breakage, and cell
death. As a physiological process, dsDNA breaks occur during meiosis when
chromosomal crossover takes place between sister chromatids as well as during
immunoglobulin class switch recombination, and transcriptions/replication when
transcription clashes with the replication fork [29].
To maintain genome stability and integrity, cells have evolved different
mechanisms to prevent and combat a variety of DNA lesions (Fig. I.2) [1]. The front
line of the mechanisms is to remove ROS before they can damage the DNA by
cellular antioxidants such as catalases, superoxide dismutase, peroxidase,
glutathione, cysteines, vitamin C, and vitamin B, among others. [30]. Removal of
existing DNA damage by different DNA repair pathways is the second line of
defense in combating the adverse consequences of DNA damage. Oxidized and
alkylated DNA base lesions can be recognized by a damage-specific DNA
glycosylase, 8-oxoGs, uracil, T/G mismatches, and alkylated DNA bases are
recognized by 8-oxoguanine DNA glycosylase (OGG1), uracil DNA glycosylase
(UNG), thymidine DNA glycosylase (TDG), and 3-alkyladenine-DNA (AAG),
respectively leading to an abasic (AP) site or ssDNA break, which initiates the BER
pathway. Misincorporated nucleotides can activate the DNA mismatch repair
(MMR) pathway. The MMR can coordinate with MutYH, a DNA glycosylase to
remove a misincorporated adenine as oppose to an 8-oxoG preventing mutations
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[31]. On the other hand, for an O6-mG that misbasepairs with thymine, the MMR
pathway serves as a direct signal for cell cycle arrest inducing a DNA damage
response or apoptosis [32]. Furthermore, the MMR pathway can recognize and
repair double helix misalignments created by small insertion or deletion loops
during DNA replication and repair [33].

Figure I.2 Types of DNA damage and DNA repair mechanism [1].

Bulky DNA adducts that can distort the DNA helix, interfere with DNA base
pairing, and obstruct gene transcription or DNA replication are recognized by
nucleotide excision repair (NER) pathway. The NER resolves bulky adducts by
removing a long fragment of DNA containing the lesion. The NER pathway scans
for the distortions of the DNA helix and recognizes a distorted DNA containing a
bulky DNA lesion. The removal of the DNA lesion involves the excision of 25-30
DNA fragment containing the damaged nucleotide leaving a large DNA gap that is
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filled in by DNA polymerase δ [34]. A nicked DNA is then sealed by DNA ligase.
Interstrand crosslinks are recognized by the Fanconi Anemia (FA) repair pathway.
The FA pathway is also involved in resolving a stalled replication fork [35].
A high level of ssDNA breaks or stalled replication fork can lead to dsDNA
breaks that are subject to homologous recombination (HR) or nonhomologous
end-joining (NHEJ) or NHEJ [36, 37]. Homologous recombination is a mechanism
to repair dsDNA breaks in proliferating cells. During HR, the damaged DNA strand
invades into the sister chromatid that is used as a template for the DNA synthesis
for completion of the repair. The dsDNA breaks can also be repaired through the
NHEJ pathway in both proliferating and nonproliferating cells. The NHEJ pathway
does not require homology of the two DNA duplex strands and only requires a few
base pairs that connect the two broken DNA ends, generating a nick that is sealed
by DNA ligase IV (LIG IV). During NHEJ, the Ku 70/80 protein recognizes the
broken ends of dsDNA strands recruiting other repair proteins including DNA
protein kinase (DNA-PK), XRCC4 and LIG IV for rejoining the broken ends [38]
In a scenario where DNA lesions escape the detection by DNA repair
machinery during DNA replication and repair and gene transcription allowing DNA
damage accumulation on the replication forks and DNA repair and transcription
intermediates, these lesions have to be bypassed by an error-prone translesion
DNA synthesis (TLS) via a variety of translesion DNA polymerases [39] to avoid
replication fork stalling, chromosomal breakage, DNA sequence rearrangements,
and cell death maintaining the integrity of the genome.
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B. The DNA Base Excision Repair Pathway
The BER pathway is a highly conserved system that exists in simple
organisms such as E. coli and yeast to multicellular eukaryotes such as humans.
The BER pathway is responsible for repairing the most common form of DNA
damage in mammalian cells, i.e., DNA base damage resulting from deamination,
depurination, oxidation, alkylation. Base excision repair is also responsible for the
repair of ssDNA breaks. Thus, BER is efficient in protecting cells from DNA
damage by removing the most frequently produced DNA lesions, especially in
mammals.
The BER pathway is mainly accomplished by five sequential steps during
which the coordination of BER enzymatic activities is essential for the efficient
removal of damaged bases [4] (Fig. I.3). The first step of BER is the recognition
and excision of the modified base to generate an abasic site. The second step is
the incision of 5’-end of the abasic site to generate an ssDNA break intermediate
with a 5’-deoxyribose phosphate (dRP) residue. In the third step, the dRP group is
removed generating a one-nucleotide gap. In the fourth step, the gap is filled
generating a nick, which will be sealed in the fifth step that completes the repair.
Base excision repair is initiated by the removal of a damaged base by a
damage-specific DNA glycosylase, leaving an abasic site. Subsequently, AP
endonuclease 1 (APE1) incises the 5’-end of the abasic site leading to ssDNA
break intermediate with dRP residue. Then the repair diverges into two subpathways depending on the number of nucleotides replaced by DNA synthesis by
DNA polymerase β (pol β), designated as the single-nucleotide (SN)-BER and
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long-patch (LP)-BER [40]. The SN-BER is initiated by the monofunctional
glycosylase that leaves an abasic site, which is further incised by APE1 [41]. The
cleaved abasic site forms an ssDNA break containing a 5’dRP native sugar, which
is processed by the lyase activity of pol β through β-elimination [42, 43]. The lyase
activity of pol β leaves a one-nucleotide gap that is filled by pol β DNA synthesis
activity creating a nicked DNA that is recognized by either DNA ligase I (LIG I) or
XRCC1/DNA ligase IIIα (LIG IIIα) complex to complete the repair [44, 45].
However, if the sugar is oxidized or reduced, they cannot be removed by pol β 5’dRP lyase activity. The removal of the modified sugar will subject the LP-BER that
involves the coordination between pol β or replication polymerases and flap
endonuclease 1 (FEN1) [43, 46, 47]. The LP-BER is accomplished through the
incorporation of 2-13 nucleotides by the DNA polymerases either via the “hit and
run” mechanism mediated by pol β and FEN1 functional coordination [4] (Fig. 3)
or strand displacement synthesis by pol β or replication polymerases and other
repair DNA polymerases creating a 5’-flap containing the modified dRP group that
is removed by FEN1, the multi-functional 5’-3’ endo- and exonuclease [42, 48].
Other DNA polymerases that perform the strand displacement synthesis during
BER include pol δ, pol ε, and pol λ through their coordination with BER cofactors,
poly(ADP-ribose) polymerase 1 (PARP1) and proliferating cell nuclear antigen
(PCNA) [47, 49-55]. The nick resulting from FEN1 flap cleavage is ligated by LIG I
to complete LP-BER [4, 56].
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Figure I.3 Base excision repair pathway [4]

The BER pathway is initiated through the recognition and removal of
damaged DNA bases by DNA glycosylases. The enzymes scan the genome for
searching for specific DNA base damage by flipping each base out of the DNA
helix. In mammals, there are eleven DNA glycosylases that specialize in the
recognition and cleavage of a variety of damaged DNA bases. The uracil DNA
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glycosylase (UNG), and the single-strand specific monofunctional uracil DNA
glycosylase 1 (SMUG) specifically remove uracil and 5-fluorouracil (5-FU)
generated during cancer therapy [57, 58]. The thymine DNA glycosylase (TDG)
and the methyl-CpG binding domain glycosylase 4 (MBD4) remove thymine
mismatches from G-T as well as uracil and 5-FU [59, 60]. The endonuclease IIIlike 1 (NTHL1) removes oxidized, ring-fragmented or saturated pyrimidines, such
as formamidopyrimidine (FaPy), 5-hydroxyuracil (5-hU), and thymine glycol (Tg)
[61, 62]. The MutY homolog DNA glycosylase (MutYH) removes adenosine (A)
opposite 8-oxoG, guanine or cytosine and 2-hydroxyadenine (2-hA) opposite G
[63]. 8-oxoguanine DNA glycosylase 1 removes the 8-oxoG and excise other
oxidized pyrimidines or ring-fragmented purines such as FaPy [64, 65]. The 3methyl-purine glycosylase (MPG) removes the alkylated purines like N3-mA, N7mG, 3-methylguanine (3-mG), and hypoxanthine [66, 67]. The Nei-like (NEIL) DNA
glycosylase 1 and 2 remove oxidized pyrimidines such as 8-oxoG, Tg, FaPy, and
5-hydroxycytosine (5-hC) on double-stranded DNA [68], while NEIL3 preferentially
removes FaPy on single-stranded DNA [69]. The DNA glycosylases can be further
classified as monofunctional and bifunctional enzymes based on the mechanism
of enzymatic reactions. The monofunctional DNA glycosylases use a water
molecule to perform a nucleophilic attack at the N-glycosidic bond between the
modified base and the sugar-phosphate backbone leading to the formation of an
abasic site [70]. Bifunctional glycosylase can cleave both the glycosidic bond and
the DNA backbone 3’-end of the damaged base through a Schiff-base intermediate
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formed by lysine [71] (Fig. I.4). The abasic site generated by DNA glycosylases on
the DNA is later recognized and incised by APE1.

Figure I.4 DNA glycosylases: in DNA repair and beyond [6]

AP endonuclease 1 has a 5’-endonuclease activity, which incises the DNA
backbone at the 5’-end of the abasic site [72, 73]. AP endonuclease 1’s incision of
the abasic site generates a 3’-hydroxyl (3’-OH) and a 5’-dRP termini, which can
further be processed by other BER enzymes [73]. AP endonuclease 1 also
possesses a 5’-3’ exonuclease activity where it can remove the damage at the 3’-
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ends, such as 3’-phosphoglycolate esters, 3’-phosphates, and 3’deoxyribose
residue generated by the hydrolysis of the phosphodiester bond by either the
bifunctional DNA glycosylases or by oxygen radicals direct attack to the DNA
backbone. These result in ssDNA break intermediates that are subject to the
cleavage by APE1 3’-exonuclease [74]. The removal of these blocking groups the
3’-end by APE1 allows the extension of the upstream strand by DNA polymerases
and nick ligation by DNA ligases. Furthermore, APE can also cleave 3’
misincorporated nucleotides to serve as a proofreading function for DNA
polymerase, which lacks this activity, such as DNA polymerase β (pol β) during
BER [75].
The functional coordination mediates efficient BER among the multiple BER
proteins and cofactors (Fig. I.4). APE1 can enhance OGG1 activity by increasing
the turnover rate of OGG1 in generating an abasic site [76]. It has been shown that
APE1 binding to an abasic site dislodges OGG1 stimulating the dissociation of the
glycosylase from its product, an abasic site, thereby increasing the catalytic
efficiency of the glycosylase.
Moreover, APE1 recruits pol β and stimulates its dRP lyase activity and gapfilling DNA synthesis activity during SN-BER [77, 78]. Additionally, APE1 enhances
the enzymatic activity of both FEN1 and LIG I during LP-BER by physically
interacting with these proteins [79]. Similarly, PCNA stimulates FEN1 cleavage and
multiple DNA polymerases syntheses to promote the removal of the damaged
strand during LP-BER [51, 80]. Also, PARP1 can stimulate DNA synthesis and
hence regulate SN-BER and LP-BER pathway by interfering with APE1/pol β
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interaction and pol β gap-filling synthesis during the repair [81]. Moreover, PARP1
can inhibit LP-BER by repressing the pol β/FEN1 “gap translation” mechanism [81].
Recent studies have also shown that MSH2 and MSH3, the MMR proteins,
stimulate pol β DNA synthesis in trinucleotide repeats during BER [82]. Thus, these
studies indicate that repair enzymes from other DNA repair pathways may
crosstalk with the BER pathway to facilitate the removal of DNA base lesions and
maintain genome stability. In addition, BER scaffolding proteins and cofactors such
as PARP1 and X-ray repair cross-complementation protein (XRCC1) are also
recruited to DNA base lesions to protect the ssDNA break from further recruiting
the downstream BER enzymes [40, 83-85] increasing the efficiency of BER.

C. BER of DNA base damage as a regulator of trinucleotide repeat
instability
Trinucleotide repeats (TNR) are microsatellites DNA that occurs in a variety
of genes involved in the regulation of gene expression and protein function [86].
TNR expansion is the cause of over 40 neurodegenerative diseases, including
Huntington’s disease (HD), Friedreich’s ataxia (FRDA), myotonic dystrophy (DM),
fragile X syndrome (FXS), among others [87, 88] (Fig. I.5). Trinucleotide repeats
undergo dynamic length changes somatically due to their propensity of forming
secondary structures such as hairpins, loops, G-quadruplexes, and bulky non-B
form structures such as R-loops during DNA replication, repair, and gene
transcription. These TNR structures modulate the activities of DNA repair proteins
that, in turn, result in repeat instability. Thus, DNA repair appears to play a critical
role in modulating TNR instability. Trinucleotide repeats are rich in Gs, As, and Cs
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that form hotspots of DNA base damage. This guanine rich sequence allows BER
to be actively involved in the repair of DNA base lesions in TNRs through which
the instability of repeats is modulated.
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Figure I.5 Types of TNR related diseases.

A role of BER in mediating TNR expansion is demonstrated by the fact that
OGG1 deficiency in HD mice attenuates CAG repeat expansion [89]. It has been
shown that during BER in TNRs, ssDNA breaks are generated through the removal
of damaged DNA bases and incision of abasic sites by DNA glycosylases and
APE1. This subsequently allows the dissociation of the repeats on the damaged
strand from its template forming the secondary structures such as hairpins along
with a multi-nucleotide gap. The gap is filled by pol β generating an extra number
of TNRs. The hairpin inhibits FEN1 conventional flap cleavage and forces the
enzyme to perform its alternate flap cleavage on a short flap attached to the hairpin
generating a nick. LIG I then seals the nick and ligates the hairpin with the newly
synthesized DNA strand resulting in repeat expansion [90] (Fig. I.6).
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Studies from our group have found that BER in a TNR tract also results in
repeat deletion [91]. We have demonstrated that a TNR hairpin can form on the
template strand. Polymerase β then skips over the hairpin to perform DNA
synthesis to displace the downstream repeats into a flap. This skip over allows
FEN1 to remove more repeats than those synthesized by pol β resulting in repeat
deletion [91]. We further demonstrate that the location of a DNA base lesion in a
TNR tract governs the repeat deletion or expansion [92]. The BER of a base lesion
located in the middle of TNRs preferentially leads to repeat deletion, whereas a
base lesion located at the 5’-side of the repeat tract results in repeat expansion.
On the other hand, BER of a base lesion located at the 3’-side of the repeats does
not affect repeat instability [92]. Interestingly, we have discovered that BER of a
base lesion located in a TNR hairpin loop leads to the opening of the hairpin
converting it into a double-flap intermediate for which the 5’-flap is removed by
FEN1, whereas the 3’-flap is removed by a 3’-flap endonuclease, Mus81/Eme1
leading the removal of a hairpin and prevention of repeat expansion [93].
Furthermore, we have shown that the regulatory role of BER in modulating TNR
instability is also modified by the coordination between BER enzymes and
cofactors. During BER in a base lesion in a hairpin loop, the 3’-exonuclease activity
of APE1 can progressively cleave the 3’-end of the upstream strand. In
coordinating with FEN1 cleavage of 5’-flap, this leads to the resolution of the
hairpin. Moreover, APE1 can stimulate the ligation of a nick by LIG I, preventing
repeat expansion [94]. Also, during BER in a TNR hairpin loop, PCNA can slide
down to the downstream to facilitate the annealing of the 3’-flap to the template
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strand. This 3’ flap reannealing creates a 5’-TNR flap that is efficiently removed by
FEN1 leading to the removal of the hairpin [95]. On the other hand, during BER in
TNRs, MMR protein complex, MSH2-MSH3 binds to the hairpin or loops formed
on the template strand and interacts with pol β to guide the polymerase to copy
the repeats within the hairpin or loop, thereby promoting repeat expansion [82].
Besides, we also show that an oxidized sugar in a TNR tract can crosslink with the
dRP lyase domain of pol β as well as LIG I to inhibit the activities of the enzymes
resulting in the accumulation of ssDNA breaks in the TNR tracks [96], potentially
promoting the repeat instability through DNA recombination. Also, we have
identified a critical role of dRP lyase domain in preventing TNR slippage and
deletion through interaction between several lysine residues in the dRP lyase
domain with the dRP group [97]. All these findings indicate an active role of BER
and DNA base damage in modulating TNR instability by coordinating with BER
cofactors, including MMR proteins. Our results further suggest that there is a
balance between the addition and removal of TNR mediated by BER that maintains
the stability of repeats. Disruption of the balance through the coordination among
BER enzymes and cofactors leads to repeat deletion or expansion (Fig. I.6).
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Figure I.6 A balance between the addition and removal of TNRs via BER governs
TNR stability.

D. R-loop biology and DNA Repair
R-loops are three-stranded nucleic acid non-B form structure, which
contains a displaced non-template ssDNA and an RNA:DNA hybrid generated
during gene transcription [5, 98] (Fig. I.7). RNA:DNA hybrids are more stable than
duplex DNA because they can adopt an intermediate conformation that resembles
part of a dsRNA (A-form) and a dsDNA (B-form) [99]. R-loops occurs when the

Figure I.7 Formation of an R-loop during gene transcription [2]
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nascent RNA transcript synthesized by an RNA polymerase re-hybridizes with the
template strand, designated the “thread-back” mechanism [100, 101]. This threadback mechanism is supported by the crystal structure of the RNA polymerase II,
showing that newly synthesized RNAs anneal back to the DNA template strand
[102]. Several factors can influence the formation of R-loops. These include
transcriptional supercoiling, the abundance of guanine-rich regions on the

A

Transcriptional supercoiling
(+)
supercoiling

(-)
supercoiling

B

G-cluster and G-rich sequence
G-rich sequence

C

DNA nick on non-template strand
RNA

Nicked ssDNA

RNA:DNA hybrid

Figure I.8 R-loop formation is favored by multiple factors [2]. A. Transcriptional
supercoiling facilitates R-loop formation by intertwining the RNA:DNA hybrid. B. G-rich
sequences facilitates R-loop formation by increasing the G:C base pairing. C. DNA nicks
on the non-template strand facilitates R-loop formation by preventing DNA:DNA
rehybridization.
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template strand, and nicks on the non-template strands [101] (Fig. I.8). The G-rich
sequences on the template strand facilitate the formation of R-loops. High Gcluster regions can also promote the stability and elongation of the RNA:DNA
hybrid by G:C base pairing [100]. Transcriptional supercoiling can stabilize the
RNA:DNA hybrid by intertwining the transcript to the template strand [101]. In
addition, a nick formed on the non-template strand can favor RNA:DNA hybrid by
preventing the non-template strand from reannealing to the template strand [101].
R-loops

are

involved

in

multiple

cellular

functions,

including

mitochondrial DNA replication, immunoglobulin (Ig) class-switch recombination
(CSR), gene expression, and transcription termination [5, 98] (Fig. I.9). In
mitochondria, DNA replication starts with the formation of an R-loop at the
origin of replication [103]. The RNA:DNA hybrid is then processed by
RNaseH1, which cleaves the part of the RNA strand. Subsequently, the
residual RNA fragment serves as a primer for DNA synthesis by DNA
polymerase γ during mitochondrial DNA replication [104]. Since the region of
repetitive switch (S) in the Ig gene contains G-rich sequences, which can
promote R-loop accumulation [105, 106], in Ig CSR, the ssDNA region of the
R-loops is recognized by B cell-specific activation-induced deaminase (AID)
that converts deoxycytidine to deoxyuridines that are then processed by the
BER and MMR machinery leaving ssDNA breaks [107-109]. The ssDNA breaks
on the S region of the Ig gene are then converted to dsDNA breaks that are
subject to NHEJ [110]. During gene transcription, R-loop can accumulate at the
pausing sites at the downstream of the poly(A) at the 3’ untranslated region,
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A

B

C

Figure I.9 The multicellular functions of R-loops [5]. A. Shows R-loops involved in
mitochondria DNA replication as the RNA ,cleaved by RNase H, is used as primer to start
replication. B. Shows R-loop involved in Immunoglobulin (Ig) class-switch recombination
as the ssDNA is targeted of deamination by AID. C. Shows R-loop involved in promoting
transcription of active genes by blocking repressive DNA methylation from DNA
methyltransferases (DNMTs).

signaling the termination of transcription [111]. Also, R-loop can accumulate at
the G-rich sequences downstream of non-methylated CpG promoters
indicating that it may protect the promoter from being hypermethylated by DNA
methyltransferases sustaining gene activation.
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R-loops can also sporadically accumulate in the genome. This
accumulation can result from the inactivation of RNA processing machinery
leading to detrimental effects to cells and causing human diseases, such as
neurodegenerative diseases and cancer [98]. Mutations in senataxin (SETX), a
putative RNA:DNA helicase, resulting in progressive degeneration motor neurons
in the brain and spinal cord [112, 113] and are associated with the
neurodegenerative disorder, oculomotor apraxia 2 (AOA2) and amyotrophic lateral
sclerosis type 4 (ALS4). SETX plays a role in transcription termination by resolving
RNA:DNA hybrids at G-rich pausing sites and promoting the cleavage of the
untranslated region of mRNAs [111]. SETX inactivation leads to a deficiency of
transcription termination, R-loop accumulation, defective DNA damage response,
and genome instability [114-116]. R-loops can readily accumulate at expanded
TNRs and has been proposed to play a role in the pathology of TNR expansion
diseases [117, 118]. R-loops accumulate at expanded GAA repeats at the frataxin
gene in FRDA and recruit the repressive heterochromatinization on the repeats
[119], thereby causing transcriptional silencing. In vitro and in vivo studies have
also shown that R-loops formed in TNR tracts cause RNA polymerase arrest and
promote TNR instability through DNA repair [117, 120, 121] (Fig. I.10). On the
other hand, in cancer, BRCA1 and BRCA2 that are associated with breast and
ovarian cancers prevent the formation of R-loops protecting chromosomes and
maintaining genome stability [122, 123].
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Figure I.10 The formation of R-loops in TNRs results in repeat instability.

R-loops can result in different forms of genome instability, including
mutations, recombination, chromosome rearrangements, and chromosome loss.
The non-template strand of R-loops can serve as a substrate for AID [106, 124].
The ssDNA is also susceptible to endogenous and exogenous DNA damage [8,
125]. Thus, AID and other APOBEC family enzymes can covert dC into dU located
in the non-template strand of an R-loop. Also, endogenous and exogenous DNA
damaging agents can oxidize, alkylate, and deaminate DNA bases or induce
depurination and depyrimidination of DNA bases located on the non-template
strand of an R-loop. All these can initiate BER and generating ssDNA break
intermediates leading to genome instability. Likewise, R-loops can lead to genome
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instability through secondary structures such as G-quadruplex and hairpins, which
form on the non-template DNA strand of R-loops. These structures can cause
replication fork stalling and DNA strand breaks leading to mutations,
recombination, and chromosome rearrangement.
To combat the deleterious consequences of persistent R-loops, cells adopt
several mechanisms to resolve R-loops. The most important and wellcharacterized mechanism that resolves R-loop is through the direct removal of the
RNA strand of R-loops by RNase H1 and H2 [126]. In addition, several helicases
have been shown to be able to unwind RNA:DNA. These include Pif1 DNA
helicase [127, 128], DHX9 (RHA) RNA helicase [129], and sen1/SETX [130].
Recent studies have shown that R-loop can also be resolved through DNA repair.
It has been shown that NER nucleases xeroderma pigmentosum group G (XPG)
and XPF are required to process the R-loops that accumulate in the absence of
AQR or SETX or in the presence of the TOP1 inhibitor camptothecin [131] resulting
in ssDNA breaks that are subsequently converted into dsDNA breaks. Moreover,
a study from the Freudenreich’s group has shown that AID-induced ssDNA breaks
in the non-template strand in R-loops, leading to the deletion of CAG repeats in
yeast suggesting that the ssDNA breaks on an R-loop may be subject to BER
through which the R-loop is resolved. The pathways for resolving R-loops need to
be elucidated.
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OVERVIEW
Base excision repair is an essential pathway that efficiently repairs DNA
base lesions, the most frequently produced DNA damage in mammalian cells. The
BER pathway also plays a critical role in active DNA demethylation to regulate
epigenetic stability. Furthermore, BER is a crucial pathway in regulating genome
stability through the processing of a variety of secondary structures formed in the
repetitive DNA sequences in the human genome. Moreover, recent studies also
indicate an essential role of BER enzymes in processing RNA during DNA
replication, repair, and microRNA biogenesis. These studies suggest that the BER
pathway can govern multicellular functions in addition to its role in DNA base lesion
repair. However, the molecular mechanisms underlying BER-mediated cellular
functions and genome and epigenome instability remain to be elucidated. To
address these knowledge gaps, we explored the roles of the coordination between
key BER enzymes and BER cofactors in modulating TNR instability through the
processing R-loops. We then explored the roles of BER in resolving R-loops
through the processing of RNA. Chapter I describes the study on how Fanconi
anemia-associated nuclease 1 can process TNRs through BER to prevent TNR
expansion by promoting repeat deletion. Chapter II describes the study on how
BER in TNR R-loops can lead to TNR deletion. Chapter III describes the study on
how BER can resolve an R-loop via the coordination between FEN1 and APE1
processing of the RNA strand during BER.
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CHAPTER 1: FANCONI ANEMIA-ASSOCIATED NUCLEASE 1 PREVENTS
CAG REPEAT EXPANSION BY PROMOTING REPEAT DELETION DURING
DNA BASE EXCISION REPAIR

ABSTRACT
Huntington’s disease (HD) is an inherited progressive neurodegenerative
disorder and caused by the expansion of CAG repeats in the encoding region of
the huntingtin (HTT) gene. It has been proposed that the root of these expansions
is the formation of secondary structures by CAG repeats during DNA replication
and repair. Previous studies have found that DNA base lesions and base excision
repair (BER) can mediate CAG repeat instability through the BER core enzymes
activities and cofactors. Here, we provide the first evidence that the Fanconi
anemia-associated nuclease 1 (FAN1) was recruited to CAG repeats upon
oxidative DNA damage to promote CAG repeat deletion through BER. We showed
that FAN1 can complement FEN1 through its 5’ flap endonuclease and 5’
exonuclease activities. We further demonstrated that PCNA and ubPCNA
coordinated with FAN1 to facilitate the attenuation of CAG repeat expansion during
BER. Our studies suggest that FAN1 can effectively process the secondary
structures by coordinating with FEN1 and PCNA during BER, thereby leading to
CAG repeat deletions.
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INTRODUCTION
Huntington’s disease (HD) is among over 40 trinucleotide repeat (TNR)
expansion disorders caused by CAG repeat expansion in the coding region of the
(HTT) huntingtin gene, resulting in the aggregation of mutant Huntingtin proteins
in

cerebral

cortex

neurons

leading

to

progressive

and

devastating

neurodegenerative symptoms [132]. The clinical symptoms for HD include
involuntary movement, dementia, speech difficulties, and impaired balance [133].
In HD patients and mouse models, the age at onset of HD depends upon the length
of the glutamine-encoding CAG repeat sequences, usually above 36-40 CAG
repeats with the longer the repeats associated with earlies age at onset (AAO)
[134]. In general, CAG repeat expansion can occur during germline transmission
and somatic cellular differentiation indicating that the disease can affect individuals
at any stage in life [88, 135]. However, the molecular mechanism underlying CAG
instability is not well understood. It has been shown that CAG instability occurs by
the formation of slipped strands such as hairpins and loops during DNA replication
[136], repair [4], recombination [137], and gene transcription [138]. These lead to
the integration of extra repeats into the genome resulting in repeat expansion
[139]. Thus, somatic CAG expansion may play a crucial role in promoting the
increased CAG repeat length up to the point of reaching the threshold leading to
neurodegenerative symptoms of the diseases and thereby governing the age at
onset of the disease.
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It has been shown that oxidative DNA damage and DNA base excision
repair are involved in modulating CAG repeat instability. CAG instability is
supported by the post-mortem analysis of HD patients and HTT mouse model
brains, which showed an increased level of oxidative DNA damage. The early
study suggests that disease progression is associated with elevated levels of
oxidized DNA bases, 8-oxoguanines (8-oxoGs) [140, 141]. Also, it has been shown
that the age-dependent somatic CAG expansion in HD mouse models is
associated with the repair of 8-oxoGs through BER [89]. The CAG repeats are GC
rich sequences that are hotspots for endogenous and exogenous sources of
oxidative DNA damaging agents [8], which can promote CAG expansion through
a “toxic oxidation cycle’, through which CAG instability occurs by multiple rounds
of DNA base damage and repair [88]. Furthermore, yeast models and in vitro
characterization showed that BER enzymes play a role in mediating somatic CAG
instability through DNA repair. It has been proposed that polymerase β (pol β)
plays a significant role in CAG repeat expansion through BER [48, 89, 90, 142].
On the other hand, flap endonuclease 1 (FEN1) prevents CAG repeat expansion
and promotes CAG repeat deletion by removing the repeats through long-patch
BER [92, 93, 95, 143]. Thus, CAG repeat instability occurs through BER by the
loss of coordination between pol β synthesis and FEN1 cleavage [89, 90] and by
BER enzyme stoichiometry, which modulates the outcome repeat instability [144,
145].
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The enzymatic activities and coordination of BER differ within human
individuals depending on age and genetic variations, suggests that somatic CAG
repeat instability is governed by the BER capacity of the human body and tissues
[146]. Furthermore, it has been suggested that DNA enzymatic activities rather
than the DNA damage levels are associated with somatic CAG expansions [145].
In HD mouse models, somatic CAG repeat instability is prevented by a deficiency
in 8-oxoguanine glycosylase (OGG1) and mismatch repair proteins, MSH2 or
MSH3 mismatch repair protein delaying the occurrence of the mutant huntingtin
phenotype [89, 147, 148]. This is because the MSH2 and MSH3 complex can
stabilize the downstream hairpin structure, which can inhibit FEN1 5’-flap
cleavage, thereby leading to CAG repeat expansion through long-patch BER [82].
Moreover, MSH2 and MSH3 interact and stimulate pol β synthesis of repeats
preventing the pol β bypass synthesis over the hairpin formed on the template
strand leading to repeat expansion [82, 92, 143]. On the other hand, APE1 can
prevent CAG repeat expansion via its 3’ exonuclease activity as well as by
stimulating DNA ligase I (LIG I) during BER in a hairpin loop. Similarly,
Mus81/EME1 3’-flap endonuclease can process the 3’-flap leading the removal of
the hairpin via the coordination with FEN1 [93]. Furthermore, the BER cofactor,
proliferating cells nuclear antigen (PCNA), a sliding clamp that participates in DNA
replication and repair can promote CAG repeat deletion in duplex DNA and prevent
repeat expansion by stimulating FEN1 cleavage and the removal of a CAG repeat
hairpin structure during BER [95]. Thus, these factors can influence the instability
on CAG repeats through BER in the context of the location of DNA base lesions
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within the CAG repeat tracts [92, 144] while the activities of BER enzymes and
cofactors are modulated during the repair [82, 94-96].

Recent genome-wide association studies (GWAS) have identified single
nucleotide polymorphism (SNPs) in the Fanconi-anemia associated nuclease 1
(FAN1) gene as a factor associated with the variation of the age at onset of HD
[149, 150]. Furthermore, increased FAN1 expression levels in HD patient stem
cells and mouse models is associated with delay of the AAO and slower
progression of HD [151]. FAN1 is an evolutionarily conserved nuclease whose
biological functions are still unclear. FAN1 was identified to be related to DNA
repair based on domain homology with other DNA repair proteins [152], its
interaction with mismatch repair proteins [153, 154], and the results from RNA
interference screening for sensitivity to DNA interstrand crosslinking agents [155].
FAN1 is a complex protein that possesses multiple structural domains, a RAD18like ubiquitin-binding zinc finger (UBZ) domain, SAP DNA binding domain, and a
virus-type replication repair nuclease (VRR_nuc) domain [155]. FAN1 exhibits a 5’
flap endonuclease activity as a dimer, which is involved in resolving interstrand
crosslinks [154-157] and a 5’ exonuclease activity as a monomer, which can
process DNA overhangs during homologous recombination (HR) [154-158]. The
FAN1 UBZ domain is essential for the interaction with the ID complex in the
Fanconi anemia (FA) pathway and the interaction with ubiquitylated PCNA
(ubPCNA) at the stalled replication fork. FAN1 can physically interact with MLH1,
MLH3, and PMS2. However, its biological function has not been elucidated [153].
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Recent studies have demonstrated that FAN1 can bind to expanded HTT CAG
repeats and prevent CAG repeat expansion independently of its nuclease activity
[151]. However, it remained to be understood how FAN1 can prevent CAG repeats
without using its nuclease activity. Here, we tested if FAN1 can use its 5’endo/exonuclease to remove CAG repeats leading to repeat deletion. We showed
that FAN1 bound to the expanded HTT CAG repeats upon oxidative DNA damage.
We found that FAN1 can complement FEN1 to remove CAG repeats leading to
repeat deletion during BER. Furthermore, we found that FAN1 promoted CAG
repeat deletion in duplex DNA and prevented CAG repeat expansion in hairpin
structures. Our studies provide the first evidence of FAN1 nuclease can prevent
CAG repeat expansion and promote CAG deletion that may potentially delay the
AAO of HD.

MATERIALS AND METHODS
Materials
The DNA oligonucleotides were from Integrated DNA Technologies (IDT,
Coralville, IA, USA). The deoxynucleotides 5’-triphosphates (dNTPs) were
purchased from Sigma-Aldrich (St. Louis, MO). The radionucleotides Cordycepin
5 -triphosphate [α32P] (5000 Ci/mmol) and [γ32P]ATP (3000 Ci/mmol) and were
purchased from Perkin Elmer Inc. (Boston, MA, USA). Terminal deoxynucleotidyl
transferase (TdT) and T4 polynucleotide kinase (PNK) were purchased from
Thermo Fisher Scientific (Waltham, MA, USA). Micro Bio-Spin 6 chromatography
columns were purchased from Bio-Rad Laboratories (Hercules, CA, USA). All

31

chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) and
Thermo Fisher Scientific (Waltham, MA, USA).

Expression and purification of BER proteins

The plasmid (pET15b) that expresses recombinant human LIG I was
transformed in E. coli BL21(AI). One colony of the transformant was inoculated
into a 5 ml Luria broth (LB) and incubated at 37 °C overnight. The cell culture then
was transferred into a 6 liters LB medium and incubated at 37 °C at 225 rpm until
OD600 reached 0.8. The protein expression was induced with the addition of 1 mM
IPTG and 0.1% L-arabinose for 18 hours at 16 °C and collected by centrifugation
at 3000 rpm for 30 min at 4 °C. Cells were pelleted and resuspended in lysis buffer
which contained 50 mM Tris–HCl pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT,
0.1% Nonidet P-40, 1 mM PMSF, and one table of Roche protease inhibitor
(Roche, Indianapolis, IN) and subjected to French Press. The cell lysates were
centrifuged at 12,000 rpm for 30 min at 4 °C. The supernatant was loaded onto a
20-ml cellulose phosphate (Sigma-Aldrich, St. Louis, MO, USA). Protein fractions
were eluted using a linear gradient of NaCl from 50 mM to 1 M. Peak fractions
were combined and dialyzed into a buffer containing 50 mM Tris–HCl pH 8.0, 500
mM NaCl, 10 mM imidazole, 7 mM 2-mercaptoethanol, 0.5% inositol, and 1 mM
PMSF. Samples were loaded onto a 5-ml Nickel-Nitrilotriacetic acid (Ni-NTA)
column. LIG I was eluted using a linear gradient of imidazole from 10 mM to 1M.
The peak fractions were combined and dialyzed into a buffer containing 30 mM
HEPES pH 7.0, 30 mM KCl, 0.1% inositol, 1 mM DTT, 1 mM EDTA, and 1 mM
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PMSF. Samples were then loaded onto a 10-ml Q Sepharose column and eluted
using a linear gradient of KCl from 30 mM to 1 M. Purified LIG I was aliquoted and
frozen at −80 °C until further use.

The plasmid (pET24b) that expresses human recombinant FEN1 was
transformed in E. coli BL21(DE3). One colony of the transformant was inoculated
into a 5 ml Luria broth (LB) and incubated at 37 °C overnight. The cell culture then
was transferred into a two liters LB medium and incubated at 37 °C at 225 rpm
until OD600 reached 0.6. The protein expression was induced with the addition of
1 mM IPTG for 3 hours at 37 °C and collected by centrifugation at 3000 rpm for 30
min at 4 °C. The collected cells were resuspended in FEN1 lysis buffer (30 mM
HEPES pH 7.5, 30 mM KCl, 0.5% inositol, 1 mM DTT, 1 mM EDTA, 1 mM
phenylmethylsulphonyl fluoride (PMSF) and one table of Roche protease inhibitor)
and lysed with a French press cell disruptor (Glen Mills, Clifton, NJ, USA). The
lysate was subject to centrifugation at 12,000 rpm for 30 minutes at 4°C and the
supernatant was loaded into a 10-ml Q Sepharose column. The flow-through was
collected and immediately loaded into a 5-ml CM Sepharose column. FEN1 protein
was eluted into a KCl linear gradient from 30 mM to 2 M. The peak fractions were
analyzed by SDS-PAGE and dialyzed into FEN1 hydrophobic buffer (30 mM
HEPES pH 7.5, 1.7 M (NH4)2SO4, 30 mM KCl, 0.5% inositol, and 1 mM PMSF).
The combined fractions were loaded into a 5-ml phenyl Sepharose column and
eluted with an (NH4)2SO4 linear gradient from 1.7 M to 0 M. The peak fractions
were analyzed by SDS-PAGE gel and tested for enzymatic activity and
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contamination. Clean fractions were combined and dialyzed into lysis buffer. The
samples were loaded into a 1-ml Mono-S column (GE Healthcare, Piscataway, NJ,
USA), and eluted using a linear gradient of KCl from 30 mM to 1 M. The purified
FEN1 was dialyzed into FEN1 storage buffer (30 mM HEPES pH 7.5, 50 mM KCl,
1 mM DTT, 1 mM EDTA, and 20% glycerol), aliquoted, and frozen at −80°C until
further use.

The plasmid (pT7) that expresses human recombinant APE1 was
transformed in E. Coli BL21(DE3). One colony of the transformant was inoculated
into a 5 ml Luria broth (LB) and incubated at 37 °C overnight. The cell culture then
was transferred into a 3 liters LB medium and incubated at 37 °C at 225 rpm until
OD600 reached 0.8. The protein expression was induced with the addition of 0.5
mM IPTG for 3.5 hours at 37 °C and collected by centrifugation at 3000 rpm for 30
min at 4 °C. The collected cells were resuspended in APE1 lysis buffer (50 mM
HEPES pH 7.5, 30 mM NaCl, 0.5% inositol, 1 mM DTT, 1 mM EDTA, 1 mM PMSF,
and one table of Roche protease inhibitor) and lysed with a French press cell
disruptor (Glen Mills, Clifton, NJ, USA). The lysate was subject to centrifugation at
12,000 rpm for 30 minutes at 4°C and the supernatant was loaded into a 10-ml Q
Sepharose column. The flow-through was collected and immediately loaded into a
10-ml SP Sepharose column. APE1 protein was eluted into a KCl linear gradient
from 30 mM to 1 M. The peak fractions were analyzed by SDS-PAGE and dialyzed
into APE1 hydrophobic buffer (30 mM HEPES pH 7.5, 1 M (NH4)2SO4, 30 mM KCl,
0.5% inositol, and 1 mM PMSF). The combined sample was loaded into a 5-ml

34

phenyl Sepharose column and eluted with a (NH4)2SO4 linear gradient from 1 M to
0 M. The peak fractions were analyzed by SDS-PAGE gel and tested for specific
activity and contamination. Clean fractions were combined and dialyzed into APE1
lysis buffer. The APE sample was loaded into a 1-ml Mono-S column (GE
Healthcare, Piscataway, NJ, USA), and eluted using a linear gradient of KCl (30
mM to 1 M). THE purified APE1 was dialyzed into APE1 storage buffer (50 mM
HEPES pH 7.5, 50 mM KCl, 1 mM DTT, 1 mM EDTA, and 20% glycerol), aliquoted,
and frozen at −80°C until further use.

The plasmid (pGEX) that expresses the human recombinant FAN1-GST tag
was expressed. FAN1-GST plasmid was transformed into Rosetta (DE3) (Millipore
Sigma, Burlington, MA). A single colony was inoculated into a 5 mL LB media
containing 100µg/ml ampicillin and 1% glucose and incubated at 37 °C overnight.
The culture was transferred to 0.5 L of LB media and incubated at 37°C at 225 rpm
until OD600 reached 0.8. The protein expression was induced by first heat shock
the culture for 5 minutes at 42 °C and later by the addition of 1 mM IPTG and the
incubation for 16 hours at 18 °C at 225 rpm. The cells were collected by
centrifugation at 3000 rpm for 30 min at 4 °C. The pellet was resuspended in lysis
buffer (20 mM Tris-HCl pH 7.3, 150 mM NaCl, 0.1% NP40, 1 mM EDTA, 1 mM
DTT, 30 mM spermidine, 1 mM PMSF, and one tablet of cOmplete protease
inhibitor) and lysed by using a French press. The lysate was subject to
centrifugation at 12,000 rpm for 30 minutes at 4°C. The supernatant was loaded
into a 1 mL Glutathione Sepharose column (GE Healthcare, Piscataway, NJ, USA).
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FAN1-GST and the resin were incubated for 2 hours at 4 °C. The column was
washed 6 times with 5 mL of FAN1 wash buffer (20 mM Tris-HCl pH 8.0, 150 mM
NaCl, 10% glycerol, 1 mM EDTA, 1 mM 2-mercaptoethanol, 1 mM PMSF, and one
tablet of cOmplete protease inhibitor). The FAN1 protein was eluted by using 5 mL
of FAN1 elution buffer (20 mM Tris-HCl pH 8.0, 20 mM glutathione, 150 mM NaCl,
10% glycerol, 1 mM EDTA, 1 mM 2-mercaptoethanol, 1 mM PMSF, and one tablet
of cOmplete protease inhibitor) and incubated for 10 minutes for each 1 mL. The
peak fractions were analyzed by SDS-PAGE and tested for enzymatic activity and
contamination. Clean fractions were combined, aliquoted, and frozen at −80°C
until further use.
Construction oligonucleotide substrates
The DNA oligonucleotide substrates containing a tetrahydrofuran (THF)
residue, an analog of an abasic site were designed to mimic a scenario where an
abasic lesion occurs in the middle of a (CAG)20 repeat tract. The guanine at the
tenth unit of (CAG)20 repeats was substituted with either a THF or uracil residue.
The sequences of the oligonucleotides are listed in Table 1. (CAG)20 duplex
substrates were constructed by annealing the THF containing oligonucleotide to
its template strand at a molar ratio of 1:3. The (CAG)20 hairpin substrate was
constructed by annealing the upstream and downstream primers with the template
at a molar ration of 1:3:5:5 in a total of 25 µl annealing reaction. The (CAG) 20
duplex and hairpin substrates were annealed by denaturation at 95 ºC for 10 min
and cooling down to room temperature.
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Enzymatic assay and repeat size measurement
The BER reactions in the presence of FAN1 were performed by incubating
various types of oligonucleotide substrates with purified APE1, pol β, FAN1, FEN1
and LIG I in BER reaction buffer containing 50 mM Tris (pH 7.5), 50 mM KCl, 0.1
mg/ml BSA, 0.1 mM EDTA, and 0.01% NP-40. The BER reconstitution reactions
of (CAG)20 duplex containing an abasic site or a uracil was performed by incubating
10 nM APE1, 5 nM pol β, 50 nM FAN1, and 25 nM LIG I with 25 nM (CAG)20 repeatcontaining a THF substrate and 0.5 units of uracil DNA glycosylase (UDG) with 25
nM (CAG)20 repeat-containing a uracil substrates. All reaction mixtures (20 µl)
were assembled on ice in BER reaction buffer in the presence of 50 µM dNTPs, 5
mM Mg2+, 5 mM ATP, and indicated concentrations of BER enzymes and
substrates. The reaction mixtures were incubated at 37 ºC for 15 min or 30 min.
Subsequently, the reaction mixtures were stopped with a 2x stopping buffer
containing 95% deionized formamide and 10 mM EDTA. To determine the length
of the repaired products during BER of an abasic site, the repaired products were
isolated, and PCR amplified. The amplified repaired products were separated by
capillary electrophoresis. The size of CAG repeats were determined by DNA
fragment analysis according to the method described previously [159].
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Table 1. Oligonucleotide sequence
Oligonucleotides
Downstream/
Damaged strand
D1.1

D1.2

D1.3

Template strand
T1.1

T1.2

Upstream strand
U1

PCR Primer
P1.1
P1.2
P1.3
P1.4
B: Biotin
U: Uracil
F: Tetrahydrofuran, THF
p: Phosphate
6: 6-Carboxyfluorescein

nt

Sequence

5’-pF CAG CAG CAG CAG CAG CAG CAG
CAG CAG CAG TA CGT ACA CTT ACT CAT
TGC-3’
99 5’-CGA GTC ATC TAG CAT CCG TA CAG
CAG CAG CAG CAG CAG CAG CAG CAG
CAF CAG CAG CAG CAG CAG CAG CAG
CAG CAG CAG TA CGT AGA CTT ACT CAT
TGC-3’
100 5’-CGA GTC ATC TAG CAT CCG TA CAG
CAG CAG CAG CAG CAG CAG CAG CAG
CAU CAG CAG CAG CAG CAG CAG CAG
CAG CAG CAG TA CGT AGA CTT ACT CAT
TGC-3’
50

100 5’-B GCA ATG AGT AAG TCT ACG TA CTG
CTG CTG CTG CTG CTG CTG CTG CTG CTG
CTG CTG CTG CTG CTG CTG CTG CTG CTG
CTG TAC GGA TGC TAG ATG ACT CG-3'
62 5’-G GCA ATG AGT AAG TCT ACG TA CTG
CTG CTG CTG CTG CTG CTG TAC GGA TGC
TAG ATG ACT CG-3'
49

5’-CGA CTC ATC TAG CAT CCG TA CAG
CAG CAG CAG CAG CAG CAG CAG CAG CA3

20
20
23
18

5’-CGA GTC ATC TAG CAT CCG TA-3’
5’-6 CAA TGA GTA AGT CTA CGT A-3’
5’-GCT CAG GTT CTG CTT TTA CCT GC-3’
5’-TGC AGG GTT ACC GCC ATC-3’
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Cell culture
Human HD induced pluripotent stem cells (iPSCs)(GM23225) were
purchased from Coriell Institute for Medical Research (Camden, NJ) and cultured
in Ham's F12 Medium/Dulbecco Modified Eagles Medium, 1:1 mixture with 2mM
L-glutamine, 10 ng/ml basic fibroblast growth factor, and 20% knock-out serum
replacement. Cells were grown at 37°C under 5% CO2. Cells were differentiated
into neuronal cells as described previously [160].
Chromatin immunoprecipitation (ChIP) was performed as previously
described [82] with minor modifications. Briefly, cells were treated with 10 mM
KBrO3 for 2 hours and untreated cells were used as a negative control. Cells were
cross-linked using 1% formaldehyde at 37°C for 30 min. The crosslinking reaction
was stopped by adding glycine to 125 mM. The DNA was sheared by sonication
for 15 cycles of 30 s ON and 30 s OFF at 4°C with Bioruptor ultrasonicator
(Diagenode, Denville, NJ). The supernatant was diluted by 10-fold. The lysate was
divided in equal aliquots, added either IgG or FAN1-ab (ab222206, Abcam Inc.,
Cambridge, UK), and incubated with protein A/G agarose beads. The ChIP
crosslinking reversal was performed using 0.2 M NaCl and incubation at 65°C for
6 h. DNA was subject to proteinase K digestion and phenol/chloroform extraction.
The recovered DNA was used for quantitative PCR.
Quantitative real-time PCR and data analysis
The quantitative PCR reaction was performed by using SYBR Green
Supermix kit (Bio-Rad Laboratories). The DNA samples from the ChIP were
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amplified using a CFX Connect Real-Time PCR Detection System (Bio-Rad
Laboratories). The HTT gene region containing CAG repeats were amplified by
using P1.3 and P1.4 primers (Table 1). The amplification was carried out by the
following PCR procedure: Denature for 98°C for 2 min, denaturation at 98°C for
20s, annealing at 51°C for 1 min, extension at 72°C for 2 min, in a total of 40 cycles.
The data analysis was done as previously described [82].

RESULTS
FAN1 is recruited to CAG repeats upon oxidative DNA damage
FAN1 interacts with several DNA repair enzymes including MSH2/MSH3,
PMS1, PMS2, PCNA, and FANC ID complex [154-156, 161]. These interactions
suggest that FAN1 is involved in different DNA repair pathways removing DNA
damage and maintaining genome stability. Previous results from Smorgorzewska
et al. 2010 have shown that FAN1 knockdown in human bone osteosarcoma
(U2OS) cells partially increased sensitivity to MMS and CPT, suggesting that FAN1
is also involved in the repair of ssDNA breaks by BER [155]. To further explore
whether FAN1 can participate in the repair of oxidative DNA damage in CAG
repeats, we initially determined if the enzyme can be recruited to the repeats in HD
neurons differentiated from the iPSCs from an HD patient using ChIP assay.
Differentiated HD neurons were treated with 10 mM potassium bromate (KBrO 3)
for 2 h. Untreated neurons were used as control. The results showed that similar
to the recruitment of DNA BER enzymes to oxidative DNA damage induced by
KBrO3 in CAG repeats in HD patient cells [82], FAN1 was recruited to the expanded
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CAG repeats in HD neurons upon the treatment with 10 mM KBrO3 (Fig. 1.1). Only
a low level of recruitment of FAN1 was detected in untreated neurons (Fig. 1.1).
IgG gave a low basal level of the signal from nonspecific binding (Fig. 1.1). Since
KBrO3 specifically induces 8-oxoGs, the results indicate that FAN1 was recruited
to 8-oxoGs in the CAG repeats in HD neurons.

% Input

20

FAN1
IgG

15
10
5
0

Untreated

Bromate

Figure 1.1 FAN1 is recruited to CAG repeats in HD differentiate neurons after
bromate treatment. HD neurons were treated with 10 mM KBrO3 (right) for 2 h.
Untreated neurons were used as control (left). An antibody against FAN1 was used to
pull down the DNA fragments containing CAG repeats that were crosslinked with FAN1
in KBrO3-treated and untreated HD neurons (red). IgG was used as control (blue) for
detecting the signal from non-specific protein binding of the antibody. (The results were
provided by Dr. Yanhao Lai at Dr. Liu’s Laboratory)
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FAN1 promotes CAG repeat deletion through BER
Previous studies by our group and others have shown that BER is actively
involved in promoting TNR repeat deletion through the removal of more TNRs by
FEN1 than those synthesized by pol β [4, 48, 82, 89, 90, 92, 95]. Previous studies
have shown that the secondary structures generated by TNRs can inhibit FEN1
cleavage, leading to repeat expansion [90]. Since FAN1 has an efficient 5’-flap
endonuclease activity and 5’-3’ exonuclease activity [152, 154-158], it is possible
that FAN1 endo/exonuclease may remove the secondary structures formed in the
CAG repeat tract. To test this hypothesis, we examined whether FAN1 can remove
CAG repeats to modulate CAG repeats instability by coordinating with FEN1
cleavage of the repeats through BER. We initially determined if FAN1 can lead to
CAG repeat instability through BER. We found that BER reconstituted with the
presence of FAN1 in the (CAG)20 repeats containing uracil or tetrahydrofuran
(THF), an analog of modified abasic site or sugar that is subject to the LP-BER
pathway. The results showed that BER of the uracil in the CAG repeats in the
presence of FAN1 predominantly led to the repaired products containing the fulllength of the (CAG)20 repeats with a small amount of the (CAG)19 and (CAG)20
products (Fig. 1.2A). In contrast, BER of the THF in the (CAG)20 repeat tract with
FAN1 predominantly led to large amount of deletion products (Fig. 1.2B).
Additional analysis of the size of the repaired products showed that FAN1 led to
the products with full-length and repeat deletion containing (CAG)5-7 and (CAG)15
and a small amount of the (CAG)21 expansion product. These results suggest that
FAN1 predominantly promoted CAG repeat deletion through the long-patch BER.
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Figure 1.2 FAN1 promotes CAG repeat deletion during long-patch BER. To test
whether FAN1 can modulate CAG repeat instability we reconstituted base excision
repair (BER) in CAG repeats duplex containing a damage in the middle of the (CAG)20
repeats. The repaired products were isolated, and PCR amplified. The PCR products
were analyzed by capillary electrophoresis and DNA fragment analysis. (A) BER of a
uracil in the (CAG)20 repeat substrate containing an uracil in the middle of the repeats.
The repaired products show the full length of the CAG repeats containing a small
amount of (CAG)19 deletion product and (CAG)21 expansion product. (B) BER of THF
in (CAG)20 in the middle of the repeats. The repaired fragment products show large
CAG repeat deletions ranging from (CAG)5 to (CAG)19 repeats and small deletion and
expansion products (CAG)19 and (CAG)21. All experiments were performed in triplicate.
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FAN1 efficiently cleaves CAG repeats during BER
Trinucleotide repeat instability is mediated by the formation of non-B form
secondary structures such as loops, hairpins, and quadruplex structures during
DNA replication [162-165] and repair [4, 90]. During BER, FEN1 flap cleavage of
TNRs balances with the synthesis of the repeats by pol β can determine whether
the repeats are deleted or expanded [4, 90]. To further examine whether the
deletion products result from FAN1 cleavage of CAG repeats during BER, we
examined FAN1 cleavage activity during BER of an abasic site (THF) in the middle
of (CAG)20 tract. Our results showed that increasing concentrations of FAN1
efficiently cleaved 1-3 CAG repeats in the absence of pol β (Figure 1.3, lanes 3-6)
compared with the FEN1 cleavage that only removed 1 CAG repeat (Figure 1.3,
lane 13). FAN1 cleavage of the repeats was significantly increased in the presence
of 5 nM pol β (Figure 1.3, lane 8-11) indicating that pol β performed DNA strand
displacement synthesis and created a repeat flap that was efficiently cleaved by
FAN1 activity. However, FEN1 cleavage was only slightly stimulated by pol β
(Figure 1.3, lane 12). These results suggest that during BER, CAG repeats on the
downstream strand formed the secondary structures that inhibited FEN1 flap
cleavage, but not FAN1 cleavage activity.
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Figure 1.3 FAN1 cleavage of CAG repeats during BER. To test FAN1 activity on CAG
repeats during BER, we performed FAN1 DNA cleavage assay on DNA substrates that
contained a (CAG)20 with a THF in the middle of the repeats. The substrate (lane 1) was
pre-nicked by APE1 (lane 2). Lanes 3-6 show FAN1 cleavage at increasing concentrations
in the absence of pol β. Lanes 7 shows pol β and substrate. Lanes 8-12 show FAN1
cleavage at increasing concentrations in the presence of pol β. Lane 12 shows FEN1
cleavage in the presence of pol β and lane 13 shows FEN1 cleavage in the absence of
pol β). All these experiments were performed in triplicates.
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FAN1 coordinates with FEN1 to cleave CAG repeats during BER.
To explore whether FAN1 can coordinate with FEN1 to remove CAG
repeats promoting repeat deletion during BER, we initially examined the FEN1
cleavage of CAG repeats during BER of an abasic site in the duplex (CAG) 20
substrate in the presence and absence of pol β with increasing concentrations of
FAN1 (Fig. 1.4A). The results showed FEN1 at 5 nM alone exhibited a weak
cleavage activity on CAG repeats on the (CAG)20 substrate in the absence of pol
β and FAN1 (Fig. 1.4A, lane 2). Increasing concentrations of FAN1 resulted in the
cleavage of multiple numbers of CAG repeats (Fig. 1.4A, lanes 3-6). Similar
cleavage activity of FEN1 on the CAG repeats in the presence of FAN1 and pol β
(5 nM) was detected (Fig. 1.4A, lanes 8-11) compared to that with the FEN1 alone
in the presence of 5 nM pol β (Fig. 1.4A, lane 7). In the presence of pol β, high
concentrations of FAN1 at 25 nM-50 nM removed all the (CAG)10 repeats at the
downstream strand (Fig. 1.4A lanes 10-11). On the other hand, FAN1 alone
showed efficient cleavage on the CAG repeats on the substrate (Fig. 1.4B, lane
2). Increasing concentrations of FEN1 had little effects on the cleavage product of
FAN1 (Fig. 1.4B, lanes 3-6). Similar results were shown in the presence of pol β
(Fig. 1.4B, lanes 8-11) compared to FAN1 and pol β alone (Fig. 1.4B, lane 7).
These results suggest that CAG repeats formed hairpin structures that inhibited
FEN1 cleavage of the repeats. The results further indicate that FAN1 employed its
5’ flap endonuclease and 5’ exonuclease activity to process hairpin structures,
thereby disrupting the structures and stimulating the removal of the repeats.
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Figure 1.4 FAN1 and FEN1 coordinate to cleave CAG repeats during BER. To test
whether FAN1 and FEN1 can coordinate to remove CAG repeats during BER, we
examined the cleavage of FAN1 and FEN1 in the presences and absence of pol β in a
nicked substrate containing a THF in the upstream strand of the CAG repeats. A) FAN1
cFEN1 cleavage during BER. Lane 1 represent substrate only. Lane 2 represents FEN1
cleavage of the CAG substrate. Lanes 3-6 represents FEN1 cleavage in the presence of
increasing concentration of FAN1. Lane 7 shows FEN1 cleavage in the presence of pol
β. Lane 8-11 shows FEN1 cleavage in the presence of pol β with increasing concentration
of FAN1. B) FEN1 complementation of FAN1 cleavage during BER. Lane 1 represent
substrate only. Lane 2 represents FAN1 cleavage of the CAG substrate. Lanes 3-6
represents FAN1 cleavage in the presence of increasing concentration of FEN1. Lane 7
shows FAN1 cleavage in the presence of pol β. Lane 8-11 shows FAN1 cleavage in the
presence of pol β with increasing concentration of FEN1. All experiments were performed
in triplicate.
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FAN1 and FEN1 coordinate to promote efficient BER on CAG repeats.
Since FEN1 is the major enzyme involved in the removal of modified bases
during long patch BER [165-167] and plays a critical role in preventing TNR
expansion during BER, we further determined if FEN1 can cooperate with FAN1
during BER in CAG repeats to facilitate the formation of the repaired products. We
reconstituted BER of an abasic site in the (CAG)20 repeat substrate in the presence
and absence of FEN1 or FAN1. The results showed that both FEN1 and FAN1
promoted the production of the repaired products during BER in the (CAG) 20
substrate (Fig. 1.5A and 1.5B). FEN1 efficiently promoted the production of the
repaired products independently of increasing concentrations of FAN1 (Fig. 1.5A,
lanes 3-7 and 1.5B, lanes 8-11). On the other hand, FAN1 cleavage led to less
repaired products in the absence of FEN1 (Fig. 1.5B, lane 3 and Fig. 1.5A, lanes
8-11). The results indicate that FAN1 and FEN1 cooperated in removing CAG
repeats, facilitating the production of the repaired products during BER.
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Figure 1.5 FAN1 and FEN1 cooperate to promote efficient BER on CAG repeats. To
test whether FEN1 and FAN1 can coordinate with each other to promote efficient BER on
CAG repeats, we performed BER reconstitution in the presence and absence of either
FAN1 or FEN1 in a nicked substrate containing a THF in the upstream strand of the CAG
repeats. A) BER in the presence and absence of FEN1 with increasing concentration of
FAN1. Lane 1 represents substrate only. Lane 2 shows FEN1 and LIGI only. Lanes 3
shows BER in the absence of FAN1. Lanes 4-7 show BER with increasing concentrations
of FAN1. Lane 8-11 show BER in the absence of FEN1 with increasing concentration of
FAN1. B) BER in the presence and absence of FAN1 with increasing concentration of
FEN1. Lane 1 represents substrate only. Lane 2 shows FAN1 and LIGI only. Lanes 3
shows BER in the absence of FEN1. Lanes 4-7 show BER with increasing concentrations
of FEN1. Lane 8-11 show BER in the absence of FAN1 with increasing concentration of
FEN1. Lane 12 for A and B represents the size marker. All experiments were performed
in triplicate.
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FAN1 attenuates CAG repeat expansion during BER in a CAG repeat hairpin.
Early studies have shown that FAN1 interacts with ubPCNA [161]. However,
it is unknown how the ubPCNA-FAN1 interaction can influence FAN1 activity, its
coordination with other enzymes, and its cleavage on CAG repeats during the
repair. To explore the role of FAN1 in processing hairpin structures during BER,
we reconstituted BER with a double-flap CAG repeat substrate that mimics an
intermediate generated by the 5’-incision of an abasic site by APE1 in a CAG
repeat hairpin in the presence of BER cofactors, PCNA, and ubiquitinated-PCNA
(ubPCNA). The results show that FAN1 promoted the formation of the repaired
products that are shorter than the expanded product by removing the downstream
CAG repeat flaps in the presence or absence of PCNA or ubPCNA (Fig. 1.6, lanes
3-5). In the presence of pol β, the shortened repaired products resulting from FAN1
cleavage were increased (Fig. 1.6, lanes 7-9). The presence of PCNA and
ubPCNA reduced the amount of the repaired products and the formation of nonexpanded products and deletion products (Fig. 1.6, lanes 7-9, lanes 15-17). The
presence of pol β led to an increase in the quantity of repaired products (Fig. 1.6,
lane 15). The results indicate that FAN1 removed the CAG repeats in the
downstream strand to promoting the formation of nonexpanded and deletion
products. Since the removal of a hairpin structure requires the removal of the
upstream flap by a nuclease such as APE1 [94], the results suggest coordination
between FAN1 and APE1 3’-5’ exonuclease activity. Our results also showed that
PCNA and ubPCNA prevented the generation of the repair products with longer
repeats attenuating repeat expansion during BER in a CAG hairpin.

50

(CAG)9

5’
3’

LIG I (25 nM)
APE1 (50 nM)
Pol β (5 nM)
PCNA (nM)
ubPCNA (nM)
FAN1 (10 nM)

−
−
−
−
−
−

−
−
−
−
−
+

+
−
−
−
−
+

(CAG)10

32

P

(CTG)7

+ + − + + +
− − − − − −
− − + + + +
− 500 − − − 500
500 − − − 500 −
+ + + + + +

−
+
−
−
−
+

+
+
−
−
−
+

+ + − + + +
+ + + + + +
− − + + + +
− 500 − − − 500
500 − − − 500 −
+ + + + + +

+
+
−
−
−
−

M
Expanded
product

Repaired
product
Deleted
product
Substrate

Lanes

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19

Figure 1.6 FAN1 promotes the removal of CAG repeats hairpin intermediate during
BER. The effect of FAN1 on the removal on CAG repeat hairpin containing an abasic site
during BER was examine by reconstituting BER in a substrate containing a hairpin
intermediate with an abasic site located in the upstream strand. Lane 1 is the substrate
only. Lane 2 corresponds to FAN1. Lanes 3-5 correspond to FAN1 and LIG I in the
presence and absence of either PCNA or ubPCNA. Lane 6 corresponds to FAN1 an pol β.
Lanes 7-9 corresponds to FAN1, LIG I, and pol β in the presence and absence of PCNA
and ubPCNA. Lane 10 represents APE1 and FAN1. Lane 11-13 corresponds to APE1,
FAN1, LIG I in the presence and absence of PCNA and ubPCNA. Lane 14 presents FAN1,
APE1, and pol β. Lanes 15-18 corresponds to FAN1, APE1, pol β, and LIG I in the
presence and absence of PCNA and ubPCNA. Lane 19 corresponds to the size marker
top band represents full hairpin size and lower band represents the removal of the
hairpin/double flap intermediates. All experiments were performed in triplicates.
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DISCUSSIONS
In the present study, we explored the role of FAN1 in modulating CAG
repeat instability during BER. We further characterized FAN1 cleavage of CAG
repeats during BER of an abasic site. Moreover, we determined the coordination
between FAN1 and FEN1 cleavage in modulating CAG repeat instability during
BER. We showed that FAN1 was recruited to CAG repeats upon oxidative DNA
base damage induced by KBrO3 (Fig. 1.1). Also, we demonstrated that FAN1
promoted CAG repeat deletion during BER in duplex DNA containing CAG repeats
during long-patch BER (Fig. 1.2B). Additional analysis on FAN1 cleavage on CAG
repeats duplex showed that FAN1 efficiently cleaved CAG cleavage using its 5’exonuclease cleavage activity and that pol β stimulated FAN1 5’ flap cleavage
during BER (Figure 1.3). We further demonstrated that FAN1 cleaved a long CAG
repeat flap independently of FEN1 cleavage (Fig. 1.4). However, we found that
FEN1 was necessary for generating the repaired products in the presence of FAN1
(Fig 1.5). Lastly, we showed that FAN1 attenuated CAG repeat expansion during
the repair of a hairpin intermediate structure through BER (Fig. 1.6). Our results
supported a model during which reactive oxygen species (ROS) induces DNA
base lesions such as 8-oxoGs on the non-template strand of a duplex CAG repeat
tract or hairpin. The 8-oxoG DNA glycosylase 1 (OGG1) removes the 8-oxoG in
the duplex or the hairpin loop, leaving an abasic site on the non- template strand.
APE1 cleaves 5’ site of the abasic site to generate ssDNA break or a nick on the
duplex DNA (Fig. 1.7A) or a hairpin loop (Fig. 1.7B). During this process, a 5’-flap
is generated by pol β DNA synthesis during BER in a duplex CAG repeats, and
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double flap intermediate is generated from the incision of CAG repeat hairpin. The
CAG flaps can form hairpin structures that inhibit FEN1 flap cleavage. The hairpin
formation allows FAN1 to use its 5’ exonuclease activity to process the end of the
hairpin and destabilize the hairpin converting it into a 5’-flap. Subsequently, FAN1
uses its 5’-endonuclease activity to remove the repeat flap leading to the formation
of deletion products and prevention or attenuation of repeat expansion (Fig. 1.7).
FAN1 is a novel protein independently discovered by four different groups
to be involved as an FA repair pathway because of its involvement in resolving
DNA interstrand crosslinks [152, 154-156]. However, up to date, no FAN1
mutations have been found in FA patients. Interestingly, FAN1 mutations have
been associated with karyomegalic interstitial nephritis (KIN) [168], colorectal
cancer [169], aging [170], and schizophrenia and autism [171] suggesting that
FAN1 has other cellular functions besides its function in multiple repair pathways.
Although FAN1 has been initially identified to be involved in ICL resistance,
however, it has been proposed that the enzyme may be involved in homologous
recombination through its 5’ to 3’ exonuclease activity [157]. The similarity of FAN1
activity and substrate specificity with other nucleases such as FEN1, EXO1, SLX1
suggests that FAN1 may act as a supplementary nuclease because of its roles in
a repair pathway that has not been identified. Moreover, the multicellular functions
of FAN1 remain to be elucidated. Recent findings on the association of FAN1
single nucleotide polymorphism with HD age of onset suggests that FAN 1 plays
an essential role in modulating the progression of TNR instability and
polyglutamine diseases [150]. Here, we provided the first evidence that FAN1 can
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be recruited to HHT gene upon oxidative DNA damage (Fig. 1.1), suggesting that
FAN1 can participate in BER to modulate the stability of expanded CAG repeats.
We also showed that FAN1 promoted repeat deletion through the coordination with
BER enzymes during long-patch BER (Fig. 1.2B). However, FAN1 only slightly
affect the repeat instability during single-nucleotide BER. It is possible that the
native sugar was efficiently removed by pol β’s dRP lyase domain [82], which acted
faster than FAN1 cleavage during the repair (Fig. 1.2A).
Our studies also indicate that FAN1 can coordinate with FEN1 in promoting
CAG repeat deletion during BER in CAG repeats. FAN1 can interact with
ubiquitinated PCNA. However, it does not interact with PCNA [161]. Conversely,
FEN1 has been shown to interact and is stimulated by PCNA [172], but inhibited
by ubPCNA [173]. The coordination among FAN1, FEN1, PCNA, and ubPCNA in
modulating TNR instability during BER needs to be elucidated. Moreover, TNRs
readily form stable secondary structures that can modify the activities of FAN1 and
FEN1 [174]. It is of importance that further studies are needed to identify the roles
of FAN1 and FEN1 and their coordination with BER cofactors and enzymes of
other DNA repair pathways interactions in preventing TNR expansion through DNA
damage and repair.
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Figure 1.7 A hypothetical model of FAN1 promoting or attenuating CAG repeat
deletion through BER. Reactive oxygen species (ROS) can cause damage on CAG
duplex or expanded CAG hairpin structures creating an 8-oxoguanine (8-oxoG). 8-oxoG
is recognized by 8-oxoguanine DNA glycosylase (OGG1) leaving an abasic site that is
incised by APE1 at the 5’-end. This cleavage will leave a nick on the duplex (A) or a double
flap intermediate on a hairpin (B). On a duplex pol β will strand displace that damage
strand creating a flap. This will result in a double flap equilibration on CAG repeats and
the formation of a hairpin on the downstream strand which will block FEN1 cleavage. The
resolution of this secondary structure will require FAN1 5’ exonuclease activity to disrupt
the hairpin structure and FEN1 to remove the flap. APE1 could remove the upstream
strand facilitating the formation of a hairpin on the template strand. CAG repeat deletion
occurs when the strand is ligated in the presence of a secondary structure on the template
strand and attenuation of expansion occurs when the double flap hairpin is removed
leading to unexpanded repaired products.
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CHAPTER 2: R-LOOPS MEDIATE TRINUCLEOTIDE REPEAT INSTABILITY
VIA MODULATION OF COORDINATED DNA BASE EXCISION
REPAIR ENZYMATIC ACTIVITIES

ABSTRACT
Trinucleotide repeat (TNR) expansion is the cause of over 40
neurodegenerative diseases. Somatic TNR expansion and deletion can be
modulated by DNA damage and repair and gene transcription. Recent studies
have pointed towards a role for R-loops formed during gene transcription in
causing TNR instability, and the base excision repair (BER) pathway mediates
CAG repeat deletions induced by R-loops in yeast. However, it remains unknown
how BER in R-loops can modulate TNR expansion and deletions. In this study, we
explored the mechanisms by which BER modulates TNR instability through Rloops. We found that APE1 incised an abasic site in a TNR R-loop, creating a
double-flap intermediate within an RNA:DNA hybrid that subsequently inhibited pol
β synthesis of TNRs. The R-loop intermediate further stimulated FEN1 cleavage
on the non-template strand 5’ flap. Surprisingly, we found that the RNA strand in
TNR-R-loops was also partially cleaved by FEN1. The partially cleaved annealed
RNA allowed pol β to skip over a TNR loop on the template strand to perform DNA
synthesis. Consequently, this resulted in the efficient removal of repeats by FEN1
and inadequate synthesis of TNRs by pol β, leading to repeat deletion. Our results
indicate that BER in a TNR R-loop preferentially causes repeat deletion through
the disruption of the balance between the addition and removal of TNRs.
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INTRODUCTION
Trinucleotide repeats (TNRs) expansions are responsible for over 40
human neurodegenerative and neuromuscular diseases including Huntington’s
disease (HD) (CAG/CTG), myotonic dystrophy type 1 (MD1) (CTG/CAG), fragile X
syndrome (FXS) (CGG/CCG), and Friedreich’s ataxia (FRDA) (GAA/TTC) among
others [86, 88, 175]. The molecular basis underlying TNRs instability is the
formation of non-B form or secondary DNA structures, including hairpins, loops,
triplexes, and G-quadruplex during DNA replication [136], repair [4], recombination
[137], and gene transcription [138]. The TNR tracts are rich in guanines, thereby
forming hotspots for DNA base lesions. The most common form of DNA damage
includes alkylated and oxidized DNA bases. It has been proposed that cycles of
repeated oxidative DNA damage, can promote somatic TNR expansions through
a “toxic oxidation cycle” [88] presumably through multiple rounds of repeat
expansion resulting from the repair of base lesions by DNA base excision repair
(BER). Thus, somatic TNR expansion may play a crucial role in allowing TNR
length to reach the threshold that leads to the evident neurodegenerative
symptoms of TNR diseases, thereby governing the age at onset of the diseases.
Recent studies from our group and other groups have shown that BER of a variety
of base lesions plays an active role in modulating TNR instability by inducing large
repeat deletions and small expansions [82, 91-95]. Furthermore, we demonstrated
that the location of a DNA base lesion in a TNR tract determines the outcome of
the repeat deletion or expansion [92].
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Gene transcription at expanded repeated sequences can lead to the
formation of R-loops [5, 176]. R-loops are generated when a nascent RNA strand
hybridizes back to its DNA template to create an RNA:DNA hybrid [5, 176]. The
RNA:DNA hybrid within an R-loop is usually longer than the transient RNA:DNA
hybrid generated by RNA priming during DNA replication. R-loops are detected in
bacteria, yeast, and humans and are implicated to be involved in many cellular
processes [5, 176]. Some physiological roles of R-loops are roles in DNA
replication initiation at mitochondrial and prokaryotic origins of replication, class
switch recombination at immunoglobulin genes, modulation of DNA methylation at
CpGs, and transcription termination. Thus, the formation of R-loops is essential for
cellular function. However, R-loop accumulation can also result in DNA damage
and genome instability [5, 176]. Defective RNA processing can result in the
accumulation of R-loops leading to activation of the DNA damage response [126,
177]. It is also suggested that R-loops can act as a mutagenic intermediate
disrupting genome integrity.
R-loops can accumulate on expanded TNRs [120, 121, 175, 178-180], and
their presence may be further promoted by the deficiency of the senataxin helicase
that disrupts the RNA:DNA hybrid [181] or depletion of RNase H enzymes that
cleave the RNA in the hybrid [126]. Moreover, R-loops on the expanded GAA,
CAG, CTG, and CGG result in a guanine-rich single-stranded region on the nontemplate strand, which can be damaged by endogenous and exogenous DNA
base damaging agents. A previous study from Su and Freudenreich (2017) has
shown that the yeast cytosine deaminase, Fcy1, causes R-loop associated CAG
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repeat contractions, and these were dependent on BER [120], indicating that BER
is responsible for TNR contractions in R-loops. However, the molecular
mechanisms by which BER promotes TNR deletion remains unknown.
We hypothesized that BER of DNA base damage in the non-template strand
of a TNR R-loop results in repeat deletion by promoting the removal of TNRs but
preventing the addition of the repeats. To test the hypothesis, we examined the
activities of BER enzymes in TNR R-loops during BER and their impact on the
stability of the repeats. We found that APE1 incised an abasic site in (GAA) 20 and
(CAG)20 repeat R-loops creating a double-flap intermediate that inhibited pol β
DNA synthesis activity significantly. In contrast, FEN1 cleavage of GAA and CAG
repeats during BER in TNR R-loops was significantly stimulated. Surprisingly, we
found that the RNA strand in TNR R-loops was also partially processed by FEN1,
promoting repeat deletion. The results indicate that BER of a DNA base lesion in
R-loops promotes TNR deletion by altering the balance between the addition and
removal of TNRs through the modulation of the activities of BER core enzymes
and processing of the RNA strand.

MATERIALS AND METHODS
Materials
The DNA and RNA oligonucleotides were synthesized by Integrated DNA
Technologies (IDT, Coralville, IA, USA). The deoxynucleotides 5’-triphosphates
(dNTPs)

were

purchased

from

Sigma-Aldrich

(St.

Louis,

MO).

The

radionucleotides α-32P-Cordycepin 5-triphosphate (5000 Ci/mmol) and γ-32P-ATP
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(3000 Ci/mmol) and were purchased from Perkin Elmer Inc. (Boston, MA, USA).
Micro Bio-Spin 6 chromatography columns were purchased from Bio-Rad
Laboratories (Hercules, CA, USA). Terminal deoxynucleotidyl transferase and T4
polynucleotide kinase were purchased from Thermo Fisher Scientific (Waltham,
MA, USA). Diethyl pyrocarbonate (DEPC) was purchased from MP Biomedicals
(Santa Ana, CA, USA). All chemical reagents were purchased from Thermo Fisher
Scientific (Waltham, MA, USA) and Sigma-Aldrich (St. Louis, MO, USA).
Purification of BER enzymes
Recombinant human AP endonuclease 1 (APE1), flap endonuclease 1
(FEN1), and DNA ligase I (LIG I) were expressed and purified as described
previously [94, 95]. Human recombinant pol β-(His)6-tag was expressed and
purified as previously reported [182] with minor modifications. Briefly, pol β
expression in two liters of cell culture was induced at OD of 0.6 and 37 ºC with
1mM isopropyl β-D-1-thiogalactopyranoside (IPTG) (VWR International, Radnor,
PA) for 3.5 hours. Cells were pelleted and resuspended with Buffer 1 containing
30 mM HEPES, pH 8.0, 500 mM NaCl, 30 mM imidazole, 1 mM EDTA, 1 mM DTT,
1 mM PMSF, and one protease inhibitor cocktail tablet (Roche, St. Louis, MO).
Cells were lysed using a French Press (GlenMills, Clifton, NJ). The soluble fraction
of the cell lysates, the supernatant was collected by centrifugation at 12,000 rpm
for 30 min. The supernatant was loaded into a Ni-NTA agarose column (Qiagen,
Hilden, Germany), followed by the wash with 5 column volume (5 CV) by Buffer 2
containing 30 mM HEPES, pH 8.0, 1 M NaCl, 30 mM imidazole, 1 mM EDTA, 1
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mM DTT, 1 mM PMSF, and one protease inhibitor cocktail tablet (Roche, St. Louis,
MO) and then by 5 CV of Buffer 1. Pol β was eluted by imidazole gradient from 30
mM to 600 mM with Buffer 3 containing 30 mM HEPES, pH 8.0, 500 mM NaCl, 600
mM imidazole, 1 mM EDTA, 1 mM DTT, and 1 mM PMSF. The peak fractions were
combined and dialyzed into 30 mM HEPES, pH 7.5, 1.7 M (NH 4)2SO4, 0.5%
inositol, and 1 mM PMSF. The dialyzed samples were loaded into a phenyl
sepharose 6 fast flow column (GE Healthcare Bio-Science, Uppsala, Sweden) and
eluted with a 30 mM (NH4)2SO4 reverse gradient. The fractions were tested for
enzymatic activity and contamination of E. Coli DNA polymerases and nucleases.
The fractions with a high level of enzymatic activity and low level of polymerase
and nuclease contamination were combined and dialyzed into the buffer containing
30 mM HEPES, pH 7.5, 30 mM KCl, 1 mM EDTA, 1 mM DTT, and 1 mM PMSF.
The dialyzed proteins were loaded on a Mono Q column (GE Healthcare Bioscience, Uppsala, Sweden) and eluted by a 1 M KCl gradient. The peak protein
fractions with the high level of enzymatic activity were combined and dialyzed into
the storage buffer containing 30 mM HEPES, pH 7.5, 50 mM KCl. 20% glycerol,
and 1 mM PMSF. The fractions were aliquoted and stored at -80 ºC.
Construction of R-loop oligonucleotide substrates
The DNA oligonucleotide substrates containing a tetrahydrofuran (THF)
residue, an analog of an abasic site, were designed to mimic a scenario where an
abasic lesion occurs in the middle of a (GAA)20 and (CAG)20 repeat tract. The
guanine at the tenth unit of (GAA)20 or (CAG)20 repeats was substituted with the
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THF residue. The sequences of the oligonucleotides are listed in Table 2. The
(GAA)20 and (CAG)20 duplex substrates were constructed by annealing the THF
containing oligonucleotide to its template strand at a molar ratio of 1:3. The (GAA) 20
and (CAG)20 R-loop substrates were constructed by annealing the damagecontaining strand, the template strand, the RNA strand containing (rGAA)20 or
(rCAG)20 at a molar ratio of 1:3:15. The (GAA)20 and (CAG)20 substrates containing
a nick were constructed by annealing the upstream and downstream primer with
the template strand at a molar ratio of 1:3:5. The double-flap (GAA)20 and (CAG)20
substrates with an RNA:DNA hybrid that mimics nicked-R-loop intermediates were
constructed by annealing the upstream, downstream, the RNA strands with
(rGAA)20 or (rCAG)20 at a ratio of 1:3:15:5 in a total of 10 μl annealing reaction.
Reagents and buffers used for constructing R-loops were prepared with 0.1% of
DEPC treated water. The duplex and nicked-duplex substrates were constructed
by denaturation at 95 ºC for 10 min and subsequent cooling down to room
temperature. The R-loop substrates and nicked-R-loop substrates were
constructed by denaturation at 96 ºC for 10 min, cooling down to 52ºC, then
immediately freezing on dry ice with 100% ethanol. The R-loop substrates
constructed were verified using 8% native polyacrylamide gel (Fig. 2.1).
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Table 2. Oligonucleotide sequence
Oligonucleotides

nt

Sequence

Downstream
/Damaged strand
D1

52

D2

50

D3

99

D4

99

5’-pFAA GAA GAA GAA GAA GAA GAA GAA GAA
GAA GAA TA CGT AGA CTT ACT CAT TGC-3’
5’ -pF CAG CAG CAG CAG CAG CAG CAG CAG
CAG CAG TA CGT ACA CTT ACT CAT TGC-3’
5’-CGA GTC ATC TAG CAT CCG TA GAA GAA GAA
GAA GAA GAA GAA GAA GAA FAA GAA GAA GAA
GAA GAA GAA GAA GAA GAA GAA TA CGT AGA
CTT ACT CAT TGC-3’
5’-CGA GTC ATC TAG CAT CCG TA CAG CAG
CAG CAG CAG CAG CAG CAG CAG CAF CAG
CAG CAG CAG CAG CAG CAG CAG CAG CAG TA
CGT AGA CTT ACT CAT TGC-3’

Template strand
T1

T2

100 5'-B GCA ATG AGT AAG TCT ACG TA TTC TTC
TTC TTC TTC TTC TTC TTC TTC TTC TTC TTC
TTC TTC TTC TTC TTC TTC TTC TTC TA CGG ATG
CTA GAT GAC TCG-3'
100 5’-B GCA ATG AGT AAG TCT ACG TA CTG CTG
CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG
CTG CTG CTG CTG CTG CTG CTG CTG TAC GGA
TGC TAG ATG ACT CG-3'

Upstream strand
U1

47

U2

49

RNA strand
R1

60

R2

60

PCR Primer
P1
P2

20
20

5’-CGA GTC ATC TAG CAT CCG TA GAA GAA GAA
GAA GAA GAA GAA GAA GAA-3’
5’-CGA CTC ATC TAG CAT CCG TA CAG CAG CAG
CAG CAG CAG CAG CAG CAG CA-3
5’-rGrArA rGrArA rGrArA rGrArA rGrArA rGrArA
rGrArA rGrArA rGrArA rGrArA rGrArA rGrArA rGrArA
rGrArA rGrArA rGrArA rGrArA rGrArA rGrArA
rGrArA-3’
5’-rCrArG rCrArG rCrArG rCrArG rCrArG rCrArG
rCrArG rCrArG rCrArG rCrArG rCrArG rCrArG
rCrArG rCrArG rCrArG rCrArG rCrArG rCrArG
rCrArG rCrArG-3’
5’-CGA GTC ATC TAG CAT CCG TA-3’
5’-6 CAA TGA GTA AGT CTA CGT A-3’

B: Biotin
F: Tetrahydrofuran, THF
p: Phosphate
r: Ribonucleotide
6: 6-Carboxyfluorescein
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Figure 2.1 R-loop and R-loop intermediate annealing. R-loop substrates containing an
(rGAA)20/(TTC)20 (A) or (rCAG)20/(CTG)20 (C) and R-loop intermediate containing an
(rGAA)20/(TTC)20 (B) or (rCAG)20/(CTG)20 (D). RNA:DNA hybrid were constructed by
annealing the 32P-labeled non-template DNA strand and RNA strand with the template
strand at a molar ratio of 1:3:15 for the 3 strands and 1:3:5:15 for the 4 strands. The primers
were incubated at 95C for 10 min and cooled down to 52C, and immediately frozen on
dry ice with 100% ethanol. Substrates were 32P-labeled at the 5’-end of the strand with an
abasic site and detected using native 8% polyacrylamide gel and phosphorimager. Lane 1
represents the single-strand non-template DNA strand. Lane 2 represents the duplex DNA.
Lane 3 represents the R-loop or R-loop intermediate substrates.
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Enzymatic assay and repeat size measurement
The BER reactions were performed by incubating various types of
oligonucleotide substrates with purified APE1, pol β, or FEN1 in BER reaction
buffer containing 30 mM HEPES (pH 7.5), 50 mM KCl, 0.1 mg/ml BSA, 0.1 mM
EDTA, and 0.01% NP-40. BER reconstitution reactions with TNR-R-loop and TNRduplex containing an abasic site was performed by incubating 50 nM APE1, 10 nM
pol β, 10 nM FEN1, and 20 nM LIG I, with 5 nM (GAA) 20 or (CAG)20 repeatcontaining substrates. All reaction mixtures (20 µl) were assembled on ice in BER
reaction buffer in the presence of 50 µM dNTPs, 5 mM Mg2+, 2 mM ATP, and
indicated concentrations of BER enzymes and substrates. The reaction mixtures
were incubated at 37 ºC for 30 min. Subsequently, the reaction mixtures were
stopped with a 2x stopping buffer containing 95% deionized formamide and 10 mM
EDTA. The repaired products were isolated and amplified by PCR to determine
the repeat size changes during BER of the abasic site. The amplified repaired
products were separated by capillary electrophoresis. The size of GAA and CAG
repeats were determined by DNA fragment analysis according to the method
described previously [159].

RESULTS
APE1 can incise an abasic site in TNR R-loops during BER.
To elucidate the molecular mechanism by which TNR R-loops induce repeat
instability through BER, we first examined if APE1 can incise the 5’-end of an
abasic site (THF) located in the middle of (GAA)20 and (CAG)20 R-loops (Fig 2.2).
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We found that APE1 at 0.1 nM-5 nM efficiently incised the abasic site located in
the duplex (GAA)20 and (CAG)20 repeat substrates, though incision of the (GAA)20
repeat duplex was less efficient than the (CAG)20 repeat substrate (Figures 1A and
1B, the top and bottom panels). In contrast, APE1 at 1 nM and 5 nM exhibited
poor 5’-incision on the abasic site in the (GAA)20 repeat R-loop (Fig. 2.2A, the panel
in the middle, lanes 2-3), though increasing concentrations from 10 nM to 100 nM
led to increased incision of the abasic site with all the abasic sites incised at 100
nM (Figure 2.1A, the panel in the middle, lanes 4-7, and the bottom panel). For the
abasic site in the (CAG)20 R-loop, APE1 at 0.1 nM-5 nM generated a significant
amount of incision product (Fig. 2.2 B, the panel in the middle, lanes 2-4, and the
bottom panel). With increasing concentrations of the enzyme from 10 nM to 100
nM, the abasic site was completely converted to the products (Figure 2.1B, the
panel in the middle, lanes 5-8, and the bottom panel). The results showed that the
APE1 cleavage activity on the abasic site in the non-template single-strand DNA
in the (GAA)20 and (CAG)20 R-loops was significantly less efficient compared with
its activity in the duplex repeats. However, high concentrations of APE1 at 50 nM
and 100 nM incised all the abasic sites in the TNR R-loops. These results are
consistent with our previous studies showing that APE1 incises an abasic site in a
single-stranded CAG repeat hairpin loop that is attenuated [93].
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Figure 2.2 APE1 incision of an abasic site on TNR R-loops. APE1 incision of an abasic
site in (GAA)20 and (CAG)20 repeats was performed on either duplex DNA substrates
containing (GAA)20 or (CAG)20 repeats or R-loop substrates containing (rGAA)20/(TTC)20 or
(rCAG)20/(CTG)20 with an abasic site located in the middle of the repeats. Substrates (10
nM) were 32P-labeled at the 5’-end of the strand containing an abasic site and incubated
with various concentrations of APE1 (1 nM-100 nM) at 37°C for 30 min. Substrates were
separated from the product in 15% urea-denaturing polyacrylamide gels. Substrates and
products were detected by a phosphorimager. Substrates are schematically illustrated
above the gels. (A) APE1 5’-incision of an abasic site on the duplex DNA substrate
containing (GAA)20 repeats or the (GAA)20 repeat R-loop substrate. Lane 1 represents the
substrate only. Lanes 2-7 represent APE1 incision activity at the concentrations of 1 nM100 nM (B) APE1 5’-incision of an abasic site on the duplex DNA substrate containing
(CAG)20 repeats or the (CAG)20 repeat R-loop substrate. Lane 1 indicates substrate only.
Lanes 2-8 indicate the reactions with APE1 at the concentrations of 0.1 nM-100 nM. The
quantification of the APE1 incision product from (A) and (B) is shown below the gels. “*”
indicates a significant difference in the products between the duplex DNA substrate and Rloop substrate (P < 0.05). “**” indicates a significant difference with P < 0.01.
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The DNA synthesis activity of DNA polymerase β synthesis is inhibited
during BER in TNR R-loops
Our previous studies have shown that pol β can bypass loop structures on
the TNR template strand to promote repeat deletion on duplex DNA [91]. Also, we
demonstrated that weak DNA synthesis activity of pol β containing the R137Q
polymorphism leads to small CAG repeat deletions [159]. Thus, we determined the
DNA synthesis activity of pol β at the different concentrations (0.1 nM to 50 nM) in
the TNR R-loops harboring the (rGAA)20/(TTC)20 and (rCAG)20/(CTG)20 with an
abasic site in the middle of the non-template strand and compared the activity with
that from the (GAA)20 and (CAG)20 duplex substrates (Figure 1.3). In this assay,
the abasic site is first cleaved by APE1, then the addition of pol β will allow
extension from the incised base to the end of the template. If the template strand
is engaged in an R-loop, access to pol β could be impeded. We found that a low
concentration of pol β at 0.1 nM failed to insert a nucleotide at both duplex and Rloop substrates containing (GAA)20 and (CAG)20 repeats (Fig. 2A and 3B, lane 3).
With increasing concentrations of pol β from 1 nM to 50 nM, pol β DNA synthesis
products were significantly increased with all the substrates (Fig. 1.3A and 1.3B,
lanes 4-8). However, at the tested concentrations, pol β produced significantly less
DNA synthesis products on the TNR R-loop substrates (~20% for the GAA and
40% for CAG repeat R-loop) than those generated from the duplex substrates
(50%-70%) (Fig. 2.3A and 2.3B, the bar charts below the gels. Nonetheless, pol β
was able to extend the cleaved substrate even when the template strand was
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engaged in an R-loop, indicating that pol β can utilize an R-loop substrate for repair
synthesis.
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Figure 2.3 Pol β DNA synthesis on TNR R-loops. Pol β DNA synthesis activity in TNR
R-loops was determined by incubating various concentrations of pol β (0.1 nM-50 nM) with
10 nM duplex DNA or R-loop substrates containing (GAA)20 or (CAG)20 with an abasic site
in the repeats at 37°C for 30 min. Substrates (10 nM) were 32P-labeled at the 5’-end of the
strand containing an abasic site and incubated with 25 nM APE1 and increasing
concentrations of pol β (0.1 nM-50 nM). Substrates and products were separated in a 15%
urea-denaturing polyacrylamide gel and detected by phosphorimager. Substrates are
schematically illustrated above the gels. Pol β DNA synthesis products are indicated by
arrows. (A) Pol β DNA synthesis on the duplex DNA or R-loop containing (GAA)20 repeats
substrates with an abasic lesion in the middle of the repeats. (B) Pol β DNA synthesis on
the duplex DNA or R-loop substrates containing (CAG)20 repeats with an abasic site
embedded in the middle of the repeats. Lane 1 represents the substrate only. Lane 2
indicates the reaction with 25 nM APE1. Lanes 3-8 indicate the reactions with APE1 and
different concentrations of pol β (0.1 nM-50 nM). The quantification of the pol β DNA
synthesis products is illustrated below the gels. “*” indicates a significant difference in the
products between the duplex DNA and R-loop substrate with P < 0.05. “**” indicates a
significant difference with P < 0.01.
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To characterize the reduced DNA synthesis activity of pol β on the TNR Rloops, we examined pol β DNA synthesis activity on nicked (CAG)20 or (GAA)20
duplex and R-loop substrates that harbor a 3’- and 5’- repeat flap on the nontemplate strand in the presence of a (rGAA)20/(TTC)20 or (rCAG)20/(CTG)20. These
substrates mimic the intermediates with an abasic site in TNR R-loops that is
incised by APE1 (Fig. 2.4). The results showed that pol β at the concentrations
ranging from 1 nM to 50 nM performed efficient DNA synthesis on the duplex
substrates containing (GAA)20 or (CAG)20 repeats (Figure 2.4A and 2.4B, the top
panels). However, no pol β DNA synthesis products were detected with the
substrate containing the GAA repeat flaps (Figure 2.4A, the bottom panel, lanes 26) indicating that pol β DNA synthesis was completely inhibited by the presence of
the 3’-repeat flaps. Pol β DNA synthesis on nicked-(CAG)20 R-loop with the 3’- and
5’-flap generated much fewer products than those generated from the duplex
repeat substrate (Fig. 2.4B, the bottom panel, lanes 2-6) indicating that the DNA
synthesis activity was also significantly inhibited by the presence of the RNA:DNA
hybrid. These results suggest that the inhibition of pol β DNA synthesis activity
resulted from a 3’-flap formed at the R-loop intermediates. To further confirm this,
we used E. coli RNase HI to remove the RNA strand of the TNR R-loops substrates
and examined the pol β DNA synthesis activity. We found that the removal of RNA
in the TNR R-loops significantly stimulated pol β DNA synthesis activity (Fig. 2.5),
indicating the necessity of the RNA strand of the R-loop for the inhibition of pol β
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activity. The results suggest that Pol β synthesis activity in the TNR R-loops was
significantly inhibited by the formation of a 3’-flap in the R-loops during BER.
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Figure 2.4 Pol β DNA synthesis on the nicked duplex TNR and nicked TNR R-loops.
Pol β DNA synthesis on the nicked duplex TNRs or R-loops resulting from APE1 incision
of an abasic site was determined by incubating the nicked TNR duplex or R-loop substrates
with pol β at 1 nM-50 nM at 37°C for 30 min. Substrates were 32P-labeled at the 5’-end of
the strand containing an abasic site. Substrates and products were separated in a 15%
urea-denaturing polyacrylamide gel and detected by phosphorimager. Substrates are
schematically illustrated above the gels. Pol β DNA synthesis products are indicated by
arrows. (A) Pol β DNA synthesis on the duplex and R-loop substrates containing (GAA)20
repeats with an abasic site in the middle of the repeats precut by APE1 incision. (B) Pol β
DNA synthesis on the duplex and R-loop substrates containing (CAG)20 repeats precut by
APE1 incision. Lane 1 represents the substrate alone. Lanes 2-6 indicate the reactions
with different concentrations of pol β at 1 nM-50 nM.
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Figure 2.5 Removal of the RNA strand in TNR R-loops by bacterial RNase HI restores
the efficient synthesis of TNRs by pol β. The effects of the RNA strand in TNR R-loops
on the DNA synthesis activity of pol β was tested by determining pol β DNA synthesis
activity in the presence of bacterial RNase HI, which cleaves the RNA strand in TNR Rloops. Nicked R-loop substrates containing the (GAA)20 (A) or (CAG)20 repeats (B) were
incubated with 5 nM pol β and various concentrations of RNase HI (0.1 nM-5 nM) at 37°C
for 30 min. Lane 1 indicates the substrate alone. Lane 2 indicates the reaction with 5 nM
pol β. Lanes 3-6 indicate the reactions with 5 nM pol β and RNase HI at 0.1 nM-5 nM.
Substrates were 32P-labeled at the 5’-end of the upstream strand of the substrates and
illustrated above the gels. Substrates and products were separated in 15% ureadenaturing polyacrylamide gel and detected by phosphorimager.
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FEN1 cleavage of TNRs is stimulated during BER in TNR R-loops
FEN1 flap cleavage activity can be inhibited by the secondary structures
formed by TNRs during DNA replication [162-165] and BER [4, 90] resulting in
TNR repeat expansion. To test whether FEN1 flap cleavage activity can also be
altered during BER in TNR R-loops, we measured the FEN1 cleavage activity on
the duplex DNA substrates containing (GAA)20 or (CAG)20 repeats with an abasic
site in the middle of the repeats and (GAA)20 and (CAG)20 R-loop substrates
containing an abasic site in the middle of the non-template strand (Fig 2.6). We
found that increasing concentrations of FEN1 at 0.1-50 nM exhibited weak flap
cleavage activity generating 1% to 20% cleavage products from the (GAA)20 repeat
duplex substrate and 1% to 50% products from the (CAG) 20 repeat duplex
substrate (Fig. 2.6A and 2.6B, lanes 3-8 and the bottom panel). Surprisingly, we
found that FEN1 at 0.1 nM cleaved ~30% of the (GAA)10 flap and 10% of the
(CAG)10 flap from the R-loop substrates (Fig. 2.6A and 2.6B, lane 3 of the middle
panel). This indicates that a (GAA)10 or (CAG)10 5’-flap was generated more
frequently or more stably in the presence of the RNA:DNA hybrid in the R-loop
substrates, thereby stimulating FEN1 flap cleavage. To characterize the FEN1
cleavage activity on the TNR R-loop substrates, we examined the FEN1 cleavage
on the nicked (GAA)20 or (CAG)20 duplex substrate and (GAA)20 or (CAG)20 nickedR-loop substrate containing a 3’-(GAA)9 or (CAG)9 flap and 5’-(GAA)10 or (CAG)10
flap with a (rGAA)20/(TTC)20 or (rCAG)20/(CTG)20 RNA: DNA hybrid (Fig. 2.7). This
time, we included the 32P label on the 5’ end of the flap, so that we could follow
the fate of the cleaved off nucleotides. Our results showed that FEN1 mainly
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cleaved one repeat from the 5’-end of the downstream strand of the (GAA)20 or
(CAG)20 nicked-duplex substrate (Figure 2.7A and 2.7B, lanes 2-6 of the top
panel), indicating that a small flap of one repeat is usually displaced. However,
FEN1 cleavage on the nicked (GAA)20 R-loop substrate predominantly generated
the (GAA)11 flap cleavage product along with the product containing one repeat
with the THF)(Figure 2.7A, lanes 2-6 of the bottom panel). Similarly, for the nicked
(CAG)20 R-loop substrate, FEN1 at all concentrations resulted in the products
containing (CAG)10 repeats and (CAG)1 with the THF (Figure 2.7B, lanes 2-6 of
the bottom panel). The results indicate that FEN1 flap cleavage activity was
significantly stimulated in the presence of the RNA:DNA hybrid during BER in the
TNR R-loops. Also, the size of the cleaved off flap is increased substantially, which
is determined by the length of the RNA:DNA hybrid. We found that the removal of
the RNA strand of the TNR R-loop substrates by bacterial RNase HI resulted in
the FEN1 cleavage products containing one repeat with the THF (Fig. 2.8)
indicating that the presence of the RNA strand was required for the stimulation of
FEN1 cleavage of long TNR flaps.
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Figure 2.6 FEN1 cleavage activity of TNRs on R-loops. FEN1 cleavage of TNRs during
BER in duplex TNRs or R-loops was determined by incubating the (GAA)20 or (CAG)20
repeat duplex and R-loop substrate with FEN1 (0.1 nM-25 nM) at 37°C for 30 min.
Substrates were 32P-labeled at the 3’-end of the strand containing an abasic site and are
illustrated above the gels. Substrates and products were separated using a 15% ureadenaturing polyacrylamide gel and detected by phosphorimager. The quantification of
FEN1 cleavage products is shown in the bar chart below the gels. (A) FEN1 cleavage
activity on duplex or R-loop substrate containing (GAA)20 repeats with an abasic site in the
middle of the repeats. (B) FEN1 cleavage on the duplex or R-loop substrate containing
(CAG)20 repeats with an abasic site in the repeats. Lane 1 indicates the substrate only.
Lane 2 indicates the reaction with 25 nM APE1. Lane 3-8 indicate the reactions with 0.1
nM-50 nM of FEN1 in the presence of 25 nM APE1. “*” indicates a significant difference
in the FEN1 cleavage products between the duplex DNA substrate and R-loop substrate
with P < 0.05. “**” indicates a significance with P < 0.01.
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Figure 2.7 FEN1 cleavage activity on the nicked TNR R-loops. FEN1 cleavage of TNRs
on the nicked duplex DNA and R-loop was examined by incubating the nicked duplex or
R-loop substrates (10 nM) containing (GAA)20 or (CAG)20 repeats with FEN1 (0.1 nM-25
nM) at 37°C for 30 min. Substrates were 32P-labeled at the 5’-end of the downstream strand
and illustrated above the gels. Substrates and products were separated using a 15% ureadenaturing polyacrylamide gel and detected by phosphorimager. FEN1 cleavage products
are indicated by arrows. (A) FEN1 cleavage activity on the duplex substrate containing
(GAA)10 repeats with an abasic site in the middle of the repeats (the gel on the top) and
double-flap substrate resulting from a (GAA)20 repeat R-loop containing an abasic site in
the middle of the repeats (the gel on the bottom). (B) FEN1 cleavage of CAG repeats on
the duplex substrate containing (CAG)20 repeats with an abasic site in the middle of the
repeats (the gel on the top) and R-loop substrate containing (CAG)20 with an abasic site in
the repeats (the gel at the bottom). Lane 1 indicates the substrate only. Lanes 2-7 indicate
the reactions with different concentrations of FEN1 (0.1 nM-25 nM).
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Figure 2. 8 Removal of the RNA strand in TNR R-loops prevents the cleavage of a
long repeat flap by FEN1. The effects of the RNA strand in R-loops on FEN1 cleavage of
TNRs was examined by detecting the size of the FEN1 cleavage products on (GAA) 20 (A)
or (CAG)20 (B) repeat R-loops in the absence or presence of bacterial RNase HI at the
concentrations of 0.1 nM-10 nM. Lane 1 represents the substrate only. Lane 2 indicates
the reaction with the substrate with 5 nM FEN1. Lanes 3-7 indicate the reactions with 5 nM
FEN1 and increasing concentrations of RNase HI at 0.1 nM-10 nM. Substrates were 32Plabeled at the 5’-end of the downstream primer and schematically illustrated above the
gels. FEN1 cleavage products were indicated by arrows and separated from the substrates
in 15% urea-denaturing polyacrylamide gel. Substrates and products were detected by
phosphorimager.
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Pol β DNA synthesis is stimulated in the presence of FEN1 during BER in
TNR R-loops
Previous studies have shown that pol β coordinates with FEN1 alternate
flap cleavage to promote TNR expansion during BER [4, 90]. To further determine
the coordination between pol β and FEN1 in a TNR R-loop, we examined if pol β
and FEN1 can influence each other during BER in the (GAA)20 and (CAG)20 R-loop
substrates by testing their enzymatic activity in the presence of the other (Fig. 2.9).
The results showed that for the nicked (GAA)20 repeat R-loop substrate, pol β did
not perform DNA synthesis in the absence of FEN1 or in the presence of a low
concentration of FEN1 at 1 nM (Fig. 2.9A, lanes 2-3). However, with increasing
concentrations of FEN1 from 5 nM to 25 nM, pol β was able to synthesize GAA
repeats, and the synthesis products were significantly increased (Fig. 2.9A, lanes
4-6). Similarly, for the nicked (CAG)20 repeat R-loop substrate, pol β DNA synthesis
products were detected in the presence of 10 nM and 25 nM FEN1 but not 1 nM
and 5 nM FEN1 (Fig. 2.9B, compare lanes 5-6 with lanes 3-4). The results indicate
that the presence of FEN1 flap cleavage stimulated the pol β synthesis of the
repeats. We then tested if pol β DNA synthesis affected the FEN1 flap cleavage
activity. The results showed that pol β at 1 nM-10 nM stimulated the
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Figure 2.9 Coordination of FEN1 flap cleavage and pol β DNA synthesis in TNR
R-loops during BER. The coordination of FEN cleavage of TNRs and pol β synthesis
of the repeats in R-loops was determined by testing pol β DNA synthesis in the
presence of various concentrations of FEN1 or by examining FEN1 cleavage activity
with the presence of different concentrations of pol β. Substrates (10 nM) were
incubated with 5 nM pol β and different concentrations of FEN1 (1 nM-25 nM) (A) and
(B) or 0.5 nM FEN1 and increasing concentrations of pol β (1 nM-50 nM) (C) and (D)
at 37°C for 30 min. (A) and (B) showed the pol β DNA synthesis activity in the presence
of FEN1 at the concentrations of 1 nM-25 nM with the nicked (GAA)20 and (CAG)20
repeat R-loop substrates containing an abasic site in the repeats. Substrates were 32Plabeled at the 5’-end of the strand containing the nick. Lane 1 represents the substrate
alone. Lane 2 indicates the reaction with 5 nM pol β. Lanes 3-6 represent the reactions
with 5 nM pol β in the presence of various concentrations of FEN1 at 1 nM-25 nM. (C)
and (D) showed FEN1 cleavage of TNRs in the presence of various concentrations of
pol β (1 nM-50 nM) with the nicked (GAA)20 and (CAG)20 repeat R-loop substrates
containing an abasic site in the repeats. Lane 1 indicates the substrate alone. Lane 2
indicates the reaction with 0.5 nM FEN1. Lanes 3-6 represent the reactions with 0.5
nM FEN1 in the presence of different concentrations of pol β (1 nM-50 nM). Substrates
were 32P-labeled at the 5’-end of the downstream strand and illustrated above the gels.
Substrates and products were separated in a 15% urea-denaturing polyacrylamide gel
and detected by phosphorimager. Pol β DNA synthesis products and FEN1 cleavage
products are indicated by arrows.
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FEN1 cleavage of the downstream long and short 5’-GAA and -CAG repeat flaps
(Fig. 2.9C and 6D, lanes 3-5) indicating that pol β DNA synthesis performed the
strand displacement synthesis to facilitate the FEN1 cleavage of a long repeat flap.
However, pol β at 25 nM and 50 nM inhibited FEN1 cleavage of a long repeat flap
and promoted FEN1 alternate flap cleavage of a short repeat flap (Fig. 2.9C and
6D, lanes 6-7). This suggests that the excessive pol β DNA synthesis at the high
concentrations displaced the RNA strand of the TNR R-loops. This then prevented
FEN1 from binding to the flaps leading to the formation of a long TNR flap.
Subsequently, the long TNR flaps form small repeat bubbles and hairpins that
inhibited FEN1 cleavage of the repeats leading to its inefficient alternate flap
cleavage of short TNR repeats.
FEN1 cleaves the RNA strand in TNR R-loops during BER
To exclude the possibility that FEN1 flap cleavage may affect the stability
of the RNA:DNA hybrid during BER in TNR R-loops, we further tested if FEN1 can
cleave the RNA from the RNA:DNA hybrid in the TNR R-loop substrates by
examining the cleavage activity of FEN1 on the RNA strand in the nicked TNR Rloop substrates (Fig. 2.10). Surprisingly, we found that FEN1 at 0.1 nM-10 nM
efficiently cleaved the RNA strand from the RNA:DNA hybrid in the nicked (GAA)20
and (CAG)20 repeat R-loop substrates (Fig. 2.10A, lanes 2-6 and lanes 8-12,
2.10B, lanes 2-5 and lanes 7-10).

We further demonstrated that the FEN1

cleavage pattern and activity on the RNA strand was not altered by pol β DNA
synthesis (Fig. 2.10A, lanes 8-12, 2.10B, lanes 7-10). The results showed that
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Figure 2.10 FEN1 cleaves the RNA strand of TNR R-loops. The cleavage of the RNA
strand of TNR R-loops by FEN1 was determined using the nicked-R-loop substrates
containing an (rGAA)20/(TTC)20 (A) or (rCAG)20/(CTG)20 (B) RNA:DNA hybrid. Substrates
were 32P-labeled at the 5’-end of the RNA strand in the R-loop substrates were
schematically illustrated above the gels. Substrates (10 nM) were incubated with FEN1
in the absence or presence of pol β at 37C for 30 min. Substrates and products were
separated in a 15% urea-denaturing polyacrylamide gel and detected by
phosphorimager. (A) FEN1 cleavage of the (rGAA)20 repeats in the GAA repeat nickedR-loop substrate in the absence or presence of 5 nM pol β. Lane 1 represents the
substrate only. Lanes 2-6 correspond to the reactions with various concentrations of
FEN1 at 0.1 nM-10 nM without pol β. Lanes 7-12 represent the reactions with FEN1 at
0.1 nM-10 nM in the presence of 5 nM pol β. (B) FEN1 cleavage of the (rCAG)20 repeats
in the CAG repeat nicked-R-loop substrate without or with 5 nM pol β. Lane 1 represents
the substrate only. Lanes 2-5 correspond to the reactions with various concentrations of
FEN1 at 0.1 nM-10 nM without pol β. Lanes 7-10 represent the reactions with FEN1 at
0.1 nM-10 nM in the presence of 5 nM pol β. All experiments were done in triplicates.
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FEN1 cleaved the RNA strand in the TNR R-loop independent of pol β DNA
synthesis during BER. The results indicate that FEN1 simultaneously removed the
downstream 5’-repeat flap and RNA strand from the RNA:DNA hybrid of a TNR-Rloop, allowing the reannealing of the upstream strand to facilitate pol β DNA
synthesis during BER.
BER on TNR R-loops promotes repeat deletion
The Su and Freudenreich study demonstrated that BER of uracils
generated from cytosine deamination in a CAG repeat R-loop, which are converted
to abasic sites by Ung1, causes repeat deletion [120]. Our previous studies have
shown that BER can induce TNR deletion during the repair of an abasic site located
in the middle of duplex TNR tracts via weak pol β DNA synthesis [82, 92]. To further
examine if the weak synthesis of TNRs by pol β and efficient removal of the repeats
by FEN1 during BER in a TNR R-loop can result in repeat deletion, we determined
TNR instability resulting from BER in a TNR R-loop (Fig. 2.11). We found that BER
in the (GAA)20 and (CAG)20 repeat R-loop substrates resulted in repaired products
containing both full length and deletion products (Fig. 2.12). Further analysis of the
size of the repaired products showed that BER led to the products with both fulllength and shorter repeats (Fig. 2.11). For the GAA repeat R-loop substrate, BER
resulted in a large amount of the deletion products containing (GAA)18 and (GAA)714

repeats (Figure 2.11A). Similarly, for the CAG repeat R-loop substrate, BER

resulted in deletion products containing (CAG)18-19 and (CAG)7-14 (Fig.2.11B).
However, BER of an abasic site in the middle of duplex GAA and CAG repeats
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Figure 2.11 BER in R-loops promotes TNR deletion. To test the effects of R-loops on
TNR instability via BER, BER in TNR R-loops was reconstituted by incubating purified
BER enzymes and the (GAA)20 and (CAG)20 repeat duplex or R-loop substrates
containing an abasic site at 37°C for 30 min. The repaired products were isolated and
amplified by PCR. The PCR-amplified repaired products were further analyzed by
capillary electrophoresis. The size of TNRs in the repaired products was determined by
DNA fragment analysis. (A) BER in the (GAA)20 duplex DNA substrate with an abasic
site in the middle of the repeats led to the production of a small amount of repeat deletion
products containing (GAA)18-19 repeats. BER in the (GAA)20 R-loop substrate containing
an abasic site in the middle of the repeats resulted in the production of repeat deletion
products of (GAA)7-14 and (GAA)18. (B) BER was reconstituted with the (CAG)20 repeat
duplex or R-loop substrate with an abasic site in the middle of the repeats. The repaired
products were isolated and amplified by PCR. The sizes of the repeats in the repaired
products were analyzed and determined by capillary electrophoresis and DNA fragment
analysis. All experiments were done in triplicates.
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Figure 2.12 BER in TNR R-loops lead to repaired products. The repaired products
resulting from BER in TNR R-loops was determined by reconstituting BER reactions with
purified APE1 (25 nM), LIG I (25 nM), pol β (1 nM-5 nM), and FEN1 (1 nM-5 nM) and 10
nM (GAA)20 (A) or (CAG)20 (B) repeat R-loop substrate. Substrates were 32P-labeled at
the 3’-end and incubated with the BER enzymes at 37°C for 30 min. The repaired
products were separated from the substrates and repair intermediates in a 15% ureadenaturing polyacrylamide gel. Substrates and products were detected by
phosphorimager. Lane 1 represents the substrate alone. Lane 2 represents the reaction
with 25 nM APE1. Lanes 3-4 represent the reactions reconstituted with purified BER
enzymes. The repaired products and intermediates are indicated by arrows. Substrates
were illustrated above the gels. All experiments were done in triplicates.
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only resulted in a small number of deletion products containing (GAA)18-19 and
(CAG)18-19 repeats, indicating loss of only 1-2 repeat units (Fig. 2.11A and 2.11B).
These results suggest that BER in TNR R-loops promotes more and larger TNR
deletions.

DISCUSSION
It has been proposed that the single-strand non-template strand of R-loops
[5, 119, 176] is susceptible to DNA damage, including DNA base damage. Thus,
it is possible that BER, acting on the damage in TNR R-loops, is involved in
mediating repeat instability. This is supported by a recent study from the
Freudenreich group showing that cytosine deamination in expanded CAG repeats
engaged in R-loops results in repeat deletions [120]. This study showed that
deletions in the CAG tract were suppressed when BER pathway members UNG1
and Apn1/APE1 were deleted, suggesting that the BER of abasic sites generated
by processing deaminated cytosines in the non-template strand of the CAG repeat
R-loops underlies the repeat instability. However, the molecular basis of R-loopmediated TNR deletion remained unknown. In this study, we explored the
underlying mechanisms of R-loop-induced repeat instability by determining the
activities of BER enzymes and their coordination during BER in TNR R-loops. We
demonstrated that an abasic site in the non-template strand of (CAG)20 and
(GAA)20 repeat R-loops was incised by APE1 resulting in a double-flap
intermediate containing an RNA:DNA hybrid with a 5’-flap and 3’-flap (Fig. 2.1).
Furthermore, pol β synthesis of repeats engaged in RNA:DNA hybrids were
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significantly inhibited, with rGAA/dTTC being even more inhibitory than
rCAG/dCTG (Fig. 2.2 and 2.3). In contrast, FEN1 flap cleavage of the 5’-flap was
significantly stimulated and biased more toward cleavage at the end of the hybrid,
resulting in the release of a large flap (Fig. 2.4 and 2.5). We found that the
presence of FEN1 facilitated pol β synthesis of TNRs (Fig. 2.9A and 2.9B).
However, the presence of pol β suppressed FEN1 cleavage of the repeats (Fig.
2.9C and 2.9D). We further demonstrated that FEN1 efficiently cleaved the 5’-end
of the RNA strand of the RNA:DNA hybrid of the TNR R-loops during BER (Fig.
2.10). Finally, BER in the R-loops led to an increase in TNR deletions and a shift
to larger deletions compared to repair in a duplex substrate (Fig. 2.11). All the
results support a hypothetical model for the repair of abasic lesions generated from
a damaged DNA base in the non-template strand of a TNR R-loop (Fig. 2.13).
APE1 incises the abasic site resulting in a single-strand break and the formation
of a double-flap intermediate with an RNA:DNA hybrid on the template strand,
along with an upstream 3’-flap and downstream 5’-flap. In the scenario where the
upstream 3’-flap reanneals back to the template, this creates a 5’-RNA flap. Pol β
will then perform strand displacement synthesis to displace the RNA strand, and
the nick will be sealed by LIG I (the subpathway on the left). Since the template
strand is relatively protected in this pathway and doesn’t have a chance to form a
DNA structure, this pathway will generally not lead to the deletion of TNRs. In the
scenario where pol β synthesis of TNRs is inhibited by the RNA:DNA hybrid, FEN1
still cleaves the downstream 5’-flap efficiently. Subsequently, FEN1 could cleave
the RNA strand in the TNR R-loops leading to the dissociation of the RNA from the
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Figure 2.13 A hypothetical model of BER in R-loops leads to TNR deletion. DNA
base damage that is induced in the non-template strand of TNR R-loops is removed by
a DNA glycosylase leaving an abasic site that is incised by APE1 at the 5’-end.
Subsequently, this results in a nick and the formation of a double-flap intermediate with
an upstream 3’-flap and 5’-downstream 5’-flap stabilized by the RNA:DNA hybrid in the
R-loop. FEN1 efficiently cleaves the 5’-flap, whereas pol β DNA synthesis is inhibited by
the 3’-flap. In a scenario where 3’-flap reannealed to the template, it displaces the RNA
strand resulting in the formation of a 5’-RNA flap. Pol β then performs a stranddisplacement DNA synthesis to dislodge the RNA strand from the template strand leaving
a nick for the ligation by LIG I. This results in no-repeat deletion (The subpathway on the
left). In a scenario where FEN1 cleaves the RNA strand leaving a short segment of RNA
that dissociates from the template. This results in the formation of a loop structure in the
template strand. Subsequently, pol β skips over the template loop generating a ligable
nick that is sealed by LIG I. Consequently, this results in more repeats removed by FEN1
than those synthesized by pol β, thereby leading to repeat deletion (the subpathway on
the right).
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R-loops and the formation of a loop structure in the template strand. Pol β then
skips over the loop to perform DNA synthesis creating a deletion. This results in
more repeats removed than synthesized during BER in R-loops, leading to large
repeat deletions (Fig. 2.11).
The role of R-loops in causing TNR instability has been implicated by
several studies [121, 178]. Loomis et al found that hairpin structures form in the
single-strand non-template strand of a CGG repeat R-loop, suggesting that these
secondary structures may underlie repeat expansions [180]. A recent study from
Su and Freudenreich has demonstrated that R-loops formed in CAG repeats result
in repeat deletions through DNA base damage and the BER pathway [120]. In this
study, we further explored how TNR deletion can be mediated by BER in TNR Rloops. We showed that BER of DNA base lesions in the non-template strand of a
TNR R-loop disrupted the coordination between pol β and FEN1 and the balance
between the synthesis of TNRs by pol β and their removal by FEN1 via the
inhibition of pol β DNA synthesis activity (Fig. 2.3) and stimulation of FEN1 flap
cleavage activity (Fig. 2.6), respectively. We demonstrated that the RNA strand of
the R-loops is playing a crucial role in modulating the activities of these BER
enzymes (Fig. 2.5 and 2.8), presumably by displacing the up- and downstream
strands to create the 3’- and 5’-flaps that subsequently inhibit pol β DNA synthesis
and stimulate FEN1 flap cleavage during BER. We propose that this situation
results in more TNR deletions either by removing the option of expansions by
incorporation of unprocessed flaps or by increasing the possibility of template
hairpins during pol β synthesis, or both.

88

Here, we identified a unique mechanism that leads to TNR deletion via BER
in R-loops through the stimulation of FEN1 cleavage of TNR flaps that occur due
to BER processing of R-loops (Fig. 2.13). However, we cannot exclude the
possibility that other BER cofactors not studied here also play a role. For example,
proliferating cell nuclear antigen (PCNA) that can stimulate FEN1 cleavage on
TNR flaps [95] may also facilitate FEN1 cleavage of TNR flaps in R-loops, thereby
further promoting repeat deletion through BER. Moreover, it is possible that the
others 5’ endonucleases, Exonuclease I (Exo I) [183] and Fanconi anemia
associated nuclease 1 (FAN1) [155] may coordinate with FEN1 to remove the 5’TNR flap formed on the non-template strand of TNR R-loops during BER. This is
supported by the fact that both Exo 1 and FAN1 can prevent TNR expansions in
mice [184, 185], and FAN1 human polymorphic variations are associated with a
late age of onset of several CAG repeat expansion neurodegenerative diseases
[149, 150, 186]. The synergistic effects of the 5’-endo and exonucleases on the
processing of TNR R-loops need to be elucidated in the future.
Our study also suggests that BER-mediated TNR deletion via R-loops can
serve as a new pathway that resolves R-loops formed in TNRs, attenuates TNR
expansion and prevents R-loop-induced gene silencing in the expanded TNRs. It
has been shown that R-loops are generated during gene transcription in open
chromatin and can inhibit DNA methyltransferase I activity ensuring the
sustainment of an open conformation of chromatin during gene transcription [187].
However, it is also found that R-loops formed on the expanded TNRs promote
heterochromatinization via the recruitment of G9a methyltransferase and
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increased H3K9me2 on the repeats inducing gene silencing [119]. This further
indicates that R-loops on TNRs, if not resolved can ultimately lead to
heterochromatinization and gene silencing. Thus, BER-mediated resolution of
TNR R-loops and associated TNR deletions may be essential protection against
the development of TNR diseases. This pathway could potentially be exploited as
a new therapy for TNR expansion diseases by targeting expanded TNRs and their
associated heterochromatinization and gene silencing.
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CHAPTER 3. FLAP ENDONUCLEASE 1 CLEAVES RNAs TO RESOLVE RLOOPS THROUGH DNA BASE EXCISION REPAIR

ABSTRACT
Flap endonuclease 1 (FEN1) is an essential enzyme that removes RNA
primers and DNA base lesions during DNA lagging strand processing and longpatch base excision repair (BER). FEN1 plays a crucial role in maintaining genome
stability and integrity. Several studies have also pointed out the role of FEN1 in
RNA processing and RNA biogenesis. However, it remains unknown how FEN1
RNA processing can facilitate genome stability and integrity. In this study, we
initially characterized the cleavage activity of FEN1 on the RNA intermediates
formed during DNA lagging strand maturation and BER in an R-loop. We found
that both human and yeast FEN1 efficiently cleaved RNA endonucleolytically. We
demonstrated that FEN1 used its tracking mechanism to track down an RNA flap
to the DNA to make a cleavage removing an RNA flap. Furthermore, we found that
FEN1 efficiently cleaved RNA during BER in an R-loop. This resolved the R-loop
via BER. Our study provides the first evidence that FEN1 endonucleolytic cleavage
of RNA promotes the resolution of R-loops via the BER pathway, thereby
maintaining genome integrity.
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INTRODUCTION
Flap endonuclease 1 (FEN1) is a central component of DNA metabolism
and plays an essential role in removing RNA primers and DNA base damage
during DNA lagging strand maturation and long-patch base excision repair (BER)
[165, 166]. It belongs to the RAD2 structure-specific nuclease superfamily and has
both endo- and exonucleolytic cleavage activity and gap endonuclease activity [53,
188-190]. During DNA replication, the DNA lagging strand is initially processed by
RNase H1 that removes the RNA primers, leaving a gap with the last
ribonucleotide attached to a downstream DNA strand. Subsequently, DNA
polymerase δ (pol δ) synthesizes nucleotides to fill in the gap and strand-displace
the downstream DNA generating a 5’-flap with the ribonucleotide. FEN1
endonucleolytically cleaves the flap and generates a nick that is sealed by DNA
ligase I (LIG I) [165, 166]. FEN1 can cleave a flap using a “tracking mechanism”
[191] during which FEN1 is loaded from the 5’-end of the flap, tracks along the flap
to the junction of between the flap and annealed region and cleaves the flap. It can
also employ a “flap threading mechanism” by binding to the junction of the flap first,
then threads the flap through itself and cleaves the flap [167]. The unique
mechanisms of flap cleavage of FEN1 make it a critical enzyme in the maintenance
of genome stability and integrity. Studies in the past decades have demonstrated
that FEN1 is also the major player that prevents sequence duplication, repeat
sequence expansion in mammals and telomere instability and fragility [165, 166,
192, 193]. Such roles of FEN1 have been further demonstrated by the fact that the
insufficiency of FEN1 function resulting from mutations is associated with lung and
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gastrointestinal cancers [194, 195] and induce a variety of mutations in multiple
cancers [196, 197].
Besides its importance in DNA replication, BER, and genome maintenance,
FEN1 is involved in other cellular functions by processing DNA and modulating
epigenetic factors. It is implicated that FEN1 can induce apoptosis by interacting
with the proteins of DNA degradosome [198]. The enzyme is also involved in the
formation of covalently closed circular (cccDNA) in the hepatitis B virus [199].
FEN1 also can modify the epigenetic features in cancer cells. It has been shown
that FEN1 can induce the upregulation of DNA methyltransferase 1 and 3a
(DNMT1 and DNMT3a) and interact with DNMT3a through proliferating cell nuclear
antigen (PCNA) [200]. This facilitates the DNA hypermethylation at the promoter
region of microRNA-200a (miRNA-200a) upregulating the expression of
hepatocyte growth factor (MET) and epidermal growth factor receptor (EGFR)
promoting cancer progression [200].
Interestingly, it has been implicated that FEN1 also processes RNA. A
recent study with FEN1 gene knockdown has suggested that FEN1 is involved in
RNA processing, ribosome biogenesis, morphogenesis, cell development, and
protein binding [201]. An early study from the Bambara group has shown that calf
thymus FEN1 can endonucleolytically cleave an RNA flap during DNA lagging
strand processing [202]. Biochemical characterization of human FEN1 cleavage
activity also shows that the enzyme can make a cleavage on mRNA and rRNA
molecules with lower activity than that on a DNA flap [203]. These findings support
the notion that FEN1 endonuclease activity can process RNA molecules. However,
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the biological significance of FEN1 RNA processing remains unknown. A recent
study has suggested that FEN1 is involved in processing the RNA in R-loops
formed on the telomeres of the leading strand DNA alleviating telomere fragility
induced by R-loops [193]. This further suggests that FEN1 can cleave an RNA flap
formed on an R-loop during DNA replication and repair.
R-loops are bulky non-B form DNA structures with an RNA:DNA hybrid and
a non-template single-strand DNA (ssDNA) that are frequently generated during
gene transcription [176]. R-loops can be physiological and pathological. They play
an essential role in mediating immunoglobulin class switch recombination [204],
CRISPR-Cas9 [205], mitochondrial DNA replication [5], and prevention of gene
silencing by suppressing DNA methylation at CpG islands [187]. However, nonscheduled spontaneous accumulation of R-loops in the genome can result in a
series of pathological consequences. These include replication fork stalling,
blockage of mRNA synthesis by RNA polymerases, DNA damage, transcriptionassociated DNA recombination, and DNA repeat sequence instability, which can
ultimately lead to cancer and neurodegeneration [176, 206].

To combat the

adverse effects, cells have evolved the multiple mechanisms to remove
unscheduled R-loops through RNase H, RNA-dependent helicases/ATPases such
as senataxin (SETX) and Fanconi anemia complementation group M (FANCM),
DNA topoisomerases, and DNA repair [176]. However, it remains to be elucidated
how the multiple mechanisms and their coordination can lead to the removal of Rloops. In particular, little knowledge about how DNA repair is involved in the
removal of R-loops. It has been proposed that the non-template ssDNAs on R-
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loops are susceptible to nucleases and reactive oxygen species (ROS) [176], thus
form hotspots of ssDNA breaks that can be repaired by BER. Since FEN1 can
process RNAs, we further hypothesize DNA base damage that occurs on the nontemplate ssDNA on R-loops induces BER during which FEN1 removes the RNA
and DNA flap in the R-loops through the coordination with DNA polymerase β (pol
β), thereby leading to the removal of R-loops. To test this hypothesis, we initially
characterized FEN1 flap cleavage activity on RNAs. We then determined the FEN1
cleavage activity of RNA and DNA on an R-loop and its functional coordination
with pol β during BER. We found both yeast and human FEN1 cleavage RNA flaps
endonucleolytically. FEN1 also used its tracking mechanism to track down to the
annealed DNA region to cleave a flap with RNA. We further demonstrated that
FEN1 was recruited to R-loops in human cells upon oxidative DNA damage. We
found that AP endonuclease 1 (APE1) incised the 5’-side of an abasic site on the
R-loop generating a double-flap intermediate with an RNA:DNA hybrid, which
inhibited DNA synthesis of pol β. FEN1 made cleavage on both 5’-DNA flap and a
RNA flap formed on the R-loop. The coordination between FEN1 and pol β led to
the repaired products and removal of the R-loop.
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MATERIALS AND METHODS
Materials
Primary normal human fibroblasts and ataxia with oculomotor apraxia type 2
(AOA2) patient fibroblasts were generously provided by Dr. Kenneth Fischbeck at
the National Institute of Neurological Disorders and Stroke/ National Institutes of
Health. Fetal Bovine Serum (FBS) and Dulbecco’s Modified Medium (DMEM) high
glucose cell culture medium were from Thermo Fischer Scientific (Waltham, MA).
RNA and DNA oligonucleotides were synthesized by Integrated DNA
Technologies (IDT, Coralville, IA) or Eurofins Genomics (Louisville, KY).
Radionucleotides, α-32P-cordycepin triphosphate (5000Ci/mmol) and γ-32Padenosine triphosphate (3000 Ci/mmol) were from PerkinElmer Inc. (Boston, MA).
T4 polynucleotide kinase was from New England BioLabs Inc. (Ipswich, MA).
Terminal deoxynucleotidyl transferase was from Thermo Fisher Scientific
(Waltham, MA). Diethyl pyrocarbonate (DEPC) was from MP Biomedicals (Santa
Ana, CA). Deoxynucleosides triphosphate was from Sigma-Aldrich (St. Louis,
MO). All other chemicals were from Thermo Fisher Scientific (Waltham, MA) and
Sigma-Aldrich (St. Louis, MO).
Purification of recombinant BER enzymes
Recombinant human APE1, pol β, FEN1, and DNA ligase I (LIG I) were
expressed in E. Coli BL21(DE3) and purified using FPLC according to the
procedures described [94, 95, 207]. For all recombinant BER enzymes, two liters
of bacterial cell culture was induced at OD of 0.6 at 37°C or 16°C (LIG I) for 3.5 h
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or 16 h (LIG I). Bacterial cells were harvested and lysed by a French Press
(GlenMills, Clifton, NJ). Soluble proteins were harvested through centrifugation at
12,000 rpm for 30 min. The supernatant was loaded on the first column. The
proteins were separated through chromatography through affinity or ion-exchange.
After a series of sequential chromatographic purification, the peak fractions of BER
proteins were pooled and dialyzed into the storage buffer, 30 mM HEPES, pH 7.5,
50 mM KCl. 20% glycerol, and 1 mM PMSF. All purified recombinant proteins were
stored at -80°C.
Oligonucleotide substrates
Duplex oligonucleotide substrates containing a 19 nt RNA strand were
constructed by annealing a downstream strand with the RNA strand with the
template strand along with an upstream strand with various lengths (29 nt-48 nt)
at a molar ratio of 1:3:5. The R-loop substrate containing an abasic site
(tetrahydrofuran, THF an analog of an abasic site) 36 nt RNA:DNA hybrid and an
abasic site were created by annealing the DNA strand containing a THF and a 36
nt RNA strand with the template strand at a molar ratio of 4:1:3. The substrate
containing a double DNA flap with a 36 nt RNA:DNA hybrid was constructed by
annealing a 34 nt upstream oligonucleotide strand, the RNA strand, a 33 nt
downstream DNA strand with a THF with the template strand at a ratio of 4:1:4:3.
Substrates were constructed in the annealing buffer (50 mM NaCl, 1 mM EDTA,
10 mM Tris, pH 7.5) that was prepared with 0.1 DEPC-treated water and generated
by denaturing at 96°C for 5 min and cool down to 25 °C. The sequences of the
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substrates were listed in Table 3. Substrates were radiolabeled at the 5’-end of the
RNA strand or the 5’-end of the upstream strand or the 5’ or 3’-end of the
downstream strand.
Table 3. Oligonucleotide sequence
Oligonucleotides
nt
Sequence
Downstream/
Damaged strand
D3.1
38 5’-pFGAT GAC GTA AAA GGA AAG AGA CGG
AAG AGG AAG AAT TC-3’
D3.2
75 5’- CTC TCG GGG CTC TGG ATT GGC CAC
CCA GTC TGC CCC CFG ATG ACG TAA AAG
GAA AGA GAC GGA AGA GGA AGA ATT C-3’
R3.1
39 5’-rCrGrU rArCrG rCrGrG rArArU rArCrU
rUrCrG rA TA CGT AGA CTT ACT CAT TGC3’
R3.2
36 5’-rCrCrA rCrCrC rArGrU rCrUrG rCrCrC
rCrCrG rGrArU rGrArC rGrUrA rArArA rGrGrA
rArArG-3’
Template strand
T3.1

60

T1.2

77

Upstream strand
U1

39

U2

29

U3
U4

20
37

5’-GGC AAT GAG TAA GTC TAC GTA TCG
AAG TAT TCC GCG TAC GTA CGG ATG CTA
GAT GAC TCG-3’
5’-GGAA TTC TTC CTC TTC CGT CTC TTT
CCT TTT ACG TCA TCC GGG GGC AGA CTG
GGT GGC CAA TCC AGA GCC CCG AGA G 3’
5’-CGA GTC ATC TAG CAT CCG TAC GTA
CGC GGA ATA CTT CGA-3’
5’-CGA GTC ATC TAG CAT CCG TAC GTA
CGC GG-3’
5’-CGA GTC ATC TAG CAT CCG TA-3’
5’-CTC TCG GGG CTC TGG ATT GGC CAC
CCA GTC TGC CCC C-3’

F: Tetrahydrofuran, THF
p: Phosphate
r: RNA
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Cleavage of RNA and BER enzymatic reactions
Cleavage of RNA by FEN1 and APE1 and BER enzymatic activity was
determined by incubating 25 nM substrates with different concentrations of FEN1
and APE1 in the presence of pol β and LIG I in BER reaction buffer (30 mM
HEPES, pH 7.5, 50 mM KCl, 0.1 mg/ml BSA, 0.1 mM EDTA, and 0.01% NP-40).
Reconstituted BER reactions were performed by incubating 25 nM substrate with
various concentrations of FEN1 in the presence of 50 nM APE1, 5 nM pol β, and
10 nM LIG I or with various concentrations of APE1 in the presence of 25 nM FEN1,
5 nM pol β, and 10 nM LIG I. Reactions (20 µl) were assembled in BER reaction
buffer containing 50 µM dNTPs, 5 mM Mg2+, and 2 mM ATP at 37 °C for 30 min.
Reactions were stopped with 2x stopping buffer (95% deionized formamide and
10 mM EDTA).
Detection of FEN1 recruitment to R-loops upon oxidative DNA damage by
immunofluorescence
Primary normal and AOA2 fibroblasts (1×105) were seeded in 200 µl DMEM
medium containing 15% FBS in an 8-well chamber slide (IbiTreat, ibidi GmbH,
Martinsried, Germany). Cells were treated with 10 mM potassium bromate (KBrO3)
for 2 h. Untreated normal and AOA2 fibroblasts were used as control. At the end
of the treatment, the fibroblasts were fixed by 4% paraformaldehyde in PBS for 30
min at 25 °C. Cells were washed with PBS three times and permeabilized with 0.1
Triton X-100 in PBS. Cells were then incubated with blocking buffer (1% BSA,
22.52 mg/ml glycine in PBST) for 30 min and subsequently with anti-RNA:DNA
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hybrid antibody (1:100, Millipore-Sigma, MABE1095, Burlington, MA) and antiFEN1 antibody (1:100, AbCam, ab17994, Cambridge, MA) in PBST containing 1%
BSA at 4°C overnight. Cells were then washed with PBS three times and incubated
with an anti-mouse and anti-rabbit secondary antibody conjugated with AlexaFluor-594 (1:1000, AbCam, ab150116) or Alexa-Fluor-488 (1:1000, AbCam,
ab150077) in PBS with 1% BSA for 1 h. Cells were washed three times with PBS
in the dark and incubated with 5 µg/μl DAPI in PBS for 1 min. Cell images were
acquired using a Nikon microscope with a 60X objective.

RESULTS
FEN1 endonucleolytically cleaves RNA in the intermediates formed during
DNA lagging strand processing.
Since FEN1 can cleave an RNA flap generated on a DNA lagging strand
[202], we initially characterized the endo/exonucleolytic activity of human and
yeast FEN1 on a nicked RNA, a RNA flap generated within a RNA strand, and a
RNA flap with a junction in between the RNA and DNA strand (Fig 3.1 and Fig 3.2).
We found that both human and yeast FEN1 mainly employed its endonucleolytic
activity to cleave the nicked RNA, the RNA flap within an RNA fragment, and the
RNA flap with an RNA-DNA junction (Fig 3.1A-1F). Human FEN1 at 1 nM-10 nM
made cleavage on the nicked RNA at multiple sites generating the products with 1
nt, 6 nt, 10 nt, and 17 nt-19 nt (Fig. 3.1A, lanes 3-5), whereas yeast FEN1 cleavage
at 1 nM-25 nM resulted in the products with 1 nt, 6 nt, and 7 nt (Fig. 3.1D, lanes 25) indicating that FEN1 cleaved RNA. For a 10 nt-RNA flap within the RNA strand,
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human and yeast FEN1 at 0.1 nM-25 nM resulted in 10 nt cleavage products (Fig.
3.1B and 1E, lanes 2-5) indicating that FEN1 made a cleavage at the junction of
the RNA flap. FEN1cleavage of a 19 nt-RNA flap attached to a DNA strand at 0.1
nM-25 nM resulted in a product with 21 nt (Fig. 3.1C and 1F, lanes 2-5). This
indicates that FEN1 efficiently cleaved the RNA flap by making a cleavage within
the DNA strand at the site of 2 nt from the RNA-DNA junction. We then examined
if FEN1 5’-3’ exonuclease also cleaved RNA during DNA lagging strand processing
using the nick and flap RNA substrates radiolabeled at the 3’-end of the
downstream strand (Fig. 3.2). Human FEN1 cleavage at 1 nM-10 nM on the nick
RNA mainly generated the 21 nt-product along with a small amount of 30 ntproduct (Fig. 3.1A, lanes 3-5) indicating that FEN1 also made the cleavage at the
RNA-DNA junction. However, yeast FEN1 at 0.1 nM-10 nM only resulted in a
product with 39 nt (Fig. 3.2D, lanes 2-5) indicating that the enzyme cleaved one
nucleotide at the 5’-end of the RNA strand. For the 10 nt-RNA flap, human FEN1
at 0.1 nM-10 nM resulted in the products with 30 nt and 21 nt, whereas yeast FEN1
at the same concentrations mainly generated the 30 nt-cleavage products (Fig.
3.2B and 2E, lanes 2-5). The results indicate that human and yeast FEN1
efficiently cleaved the 10 nt-RNA within the RNA. Human FEN1 also made the
endonucleolytic cleavage at the DNA (Fig. 3.2B, lanes 3-5) For the 19 nt RNA flap
attached to the DNA strand, human FEN1 cleavage only produced 21 nt (Fig. 3.2C,
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Figure 3.1 FEN1 endo-cleavage of RNA/DNA hybrids. To test FEN1 RNA
endonuclease cleavage activity in the context of RNA/DNA hybrids, we performed
FEN1 RNA cleavage assay using Okazaki fragment intermediate substrates
radioactively labeled at the 5’ end of the downstream strand containing a RNA and
DNA on the same strand (RNA blue segments). (A) Human FEN1 RNA cleavage on
nicked RNA:DNA hybrid Okazaki fragment intermediate substrate. (B) Human FEN1
RNA cleavage on RNA/DNA hybrid Okazaki fragment intermediate containing a 9nt
RNA flap. (C) Human FEN1 RNA cleavage on duplex DNA containing a 19nt RNA flap.
(D) Yeast FEN1 RNA cleavage on nicked RNA:DNA hybrid Okazaki fragment
intermediate substrate. (E) Yeast FEN1 RNA cleavage on RNA/DNA hybrid Okazaki
fragment intermediate containing a 9nt RNA flap. (F) Yeast FEN1 RNA cleavage on
duplex DNA containing a 19nt RNA flap. Lane 1 represents substrate only. Lanes 2-6
represent increasing concentrations of FEN1. Substrates and products were separated
in a 15% urea-denaturing polyacrylamide gel and detected by phosphorimager. All
experiments were performed in triplicates.
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Figure 3.2 FEN1 exo-cleavage of RNA/DNA hybrids. To test FEN1 RNA
exonuclease cleavage activity in the context of RNA/DNA hybrids, we performed FEN1
RNA cleavage assay using Okazaki fragment intermediate substrates radioactively
P32 labeled at the 3’ end of downstream strand containing a RNA and DNA on the
same strand (RNA blue segments). (A) Human FEN1 RNA cleavage on nicked
RNA:DNA hybrid Okazaki fragment intermediate substrate. (B) Human FEN1 RNA
cleavage on RNA/DNA hybrid Okazaki fragment intermediate containing a 9nt RNA
flap. (C) Human FEN1 RNA cleavage on duplex DNA containing a 19nt RNA flap. (D)
Yeast FEN1 RNA cleavage on nicked RNA:DNA hybrid Okazaki fragment intermediate
substrate. (E) Yeast FEN1 RNA cleavage on RNA/DNA hybrid Okazaki fragment
intermediate containing a 9nt RNA flap. (F) Yeast FEN1 RNA cleavage on duplex DNA
containing a 19nt RNA flap. Lane 1 represents substrate only. Lanes 2-6 represent
increasing concentrations of FEN1. Substrates and products were separated in a 15%
urea-denaturing polyacrylamide gel and detected by phosphorimager. All experiments
were done in triplicates.
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lanes 2-5) indicating that the enzyme made a cleavage at the junction between the
19 the flap. However, yeast FEN1 cleavage on the flap resulted in the products
with 21 nt, 20 nt, and 18 nt (Figure 3.2F, lanes 2-5). The results indicate that human
and yeast FEN1 exerted a different cleavage pattern by making cleavages at
distinct sites in the RNA strand.
FEN1 can track down to the DNA region to remove an RNA primer
Since FEN1 also exhibits a 5’-3’-exonuclease activity, we then asked if
FEN1 also used its 5’-3’-exonuclease activity to continue to remove the RNA
strand after the enzyme cleaved an RNA flap. We tested this possibility by
examining human FEN1 cleavage activity on the substrate containing the 10 ntRNA flaps with a 9 nt-RNA annealed on the template strand at various time
intervals (Fig. 3.3). The substrate was radiolabeled at the 3’-end of the downstream
strand for detecting the FEN1 exonucleolytic cleavage products. The results
showed that FEN1 endonucleolytically cleaved the 10 nt-RNA flaps leaving a 31
nt-cleavage product at the time of intervals of 1-60 min (Fig. 3.3, lanes 1-8).
Starting from 5 min, a 21 nt-cleavage product was generated (Fig. 3.3, lanes 4-8)
indicating that FEN1 made the cleavage at the junction between the RNA and DNA
strand after FEN1 removed the RNA flap. Moreover, we found that FEN1 exhibited
its 5’-3’ exonuclease activity within the annealed DNA strand further demonstrating
that FEN1 used its endonucleolytic activity to remove the RNA. Quantification of
the FEN1 cleavage products showed that FEN1 endonucleolytic cleavage activity
removed the 10 nt-RNA flaps within 15 min along with a significant increase of the
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endonucleolytic cleavage at the junction between RNA and DNA (Fig 3.3B). This
suggests that FEN1 removed the RNA flap leaving a nicked RNA for the enzyme
to track down to the junction between RNA and DNA and made the endonucleolytic
cleavage and removed the RNA strand.
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Figure 3.3 FEN1 cleavage of RNA and DNA tracking in an RNA/DNA hybrid. The
rate of FEN1 RNA exonuclease cleavage activity in the context of RNA/DNA hybrids
was performed by a FEN1 RNA cleavage assay using Okazaki fragment intermediate
at different time intervals. (A) shows 5 nM of FEN1 cleavage at increasing time points
were performed by using 25nM of 32P labeled substrate at the 3’ end of the downstream
strand containing an RNA and DNA on the same strand (RNA blue segments). Lane 1
represents substrate only. Lane 2 represents FEN1 at 0 minutes and lanes 2 to 8
represents increasing incubation time. Lane 9 is a 20 nt size marker. (B) Quantification
results from A. Blue line indicates FEN1 RNA cleavage segment and red line indicates
FEN1 cleavage segments. Substrates and products were separated in a 15% ureadenaturing polyacrylamide gel and detected by phosphorimager. All experiments were
performed in triplicates.
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FEN1 is recruited to R-loops in human cells upon oxidative DNA damage and
cleaves the RNA in an R-loop during BER
Since a recent study has implicated a role of FEN1 in processing R-loops
formed in telomeres [193], and the non-template strand of an R-loop is susceptible
to DNA base damage, we asked if FEN1 can cleave the RNA in R-loops formed
during gene transcription facilitating the resolution of R-loops during BER. We
initially examined the recruitment of FEN1 to R-loops and its dependency on
oxidative DNA damage in normal human fibroblasts and senataxin gene-deficient,
Ataxia oculomotor apraxia type 2 (AOA2) fibroblasts using immunofluorescence
(Fig. 3.4). The results showed that in untreated normal fibroblasts, R-loops (red)
and FEN1 (green) were detected in the nucleus of the fibroblasts. However, a little
signal of the co-localization of R-loop and FEN1 was detected (Fig. 3.4A). Upon
the treatment of 10 mM KBrO3 that specifically induces 8-oxoguanines (8-oxoGs)
[208], the colocalization of R-loop and FEN1 was detected in a few numbers of
the nucleus (Fig 3.4B). For the untreated AOA2 fibroblasts, which usually exhibit
the accumulation of R-loops because of the deficiency of the senataxin helicase
activity [181], the R-loop-FEN1 colocalized was detected in a few nuclei (Fig.
3.4C). Upon the treatment of KBrO3, the signal of the R-loop-FEN1 colocalization
was significantly increased in AOA2 fibroblasts (Fig. 3.4D). The results indicate
that FEN1 was recruited to R-loops upon oxidative DNA damage suggesting that
FEN1 processed the RNA in an R-loops during BER of oxidative DNA damage in
AOA2 fibroblasts. We then examined FEN1 cleavage activity on the RNA on an Rloop containing a 36 nt RNA:DNA hybrid and an abasic site in the middle of the
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Figure 3. 4 FEN1 recruitment to R-loops upon oxidative DNA damage. Primary
normal fibroblast cells were either left untreated as control (A) or treated with 10 mM
KBrO3 for 2 hours. (B). AOA2 fibroblast cells were either left untreated as control (C) or
treated with 10 mM KBrO3 for 2 hours. (D). Anti-RNA:DNA hybrid antibody (S9.6) were
used to detect R-loop accumulation on human cells. Anti-FEN1 antibody was used to
detect the colocalization of FEN1 to the R-loop. Anti-rabbit secondary antibody
conjugated with Alexa-Fluor-594 were used for imaging detection. Cell images were
acquired using a Nikon microscope with a 60X objective. The image exposures were
adjusted to show the presence of foci.

non-template (Fig. 3.5). FEN1 cleavage of the RNA was determined with the
substrate with an intact abasic site (THF) or the substrate that mimics the
intermediate that is precut by APE1 containing a 3’- and 5’-DNA flaps with an
RNA:DNA hybrid (Fig. 3.5). We found that FEN1 at 1 nM-25 nM endonucleolytically
cleaved the RNA strand from the R-loop substrate with an abasic site incised by
50 nM APE1 (Fig. 3.5A, lanes 3-6). Similarly, FEN1 at the same concentrations
endonucleolytically cleaved the RNA strand on the double-flap intermediate (Fig.
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3.5B, lanes 3-6). The enzyme exhibited a unique flap cleavage pattern by initially
cleaving 2 to 4 ribonucleotides and subsequently removing a series of larger RNA
oligonucleotides (Fig. 3.5A and 5B, lanes 5-6). This further suggests that FEN1
also tracked along with the RNA strand and made an endonucleolytic cleavage of
the RNA in an R-loop during BER. We then compared the activity for FEN1 to
remove the downstream 5’-DNA flap with its cleavage activity on the RNA in the
double-flap substrate with an RNA:DNA hybrid (Fig. 3.6). We found that FEN1
cleavage of the 5’-flap is much faster than its cleavage (Fig. 3.5, compare the blue
line with the red line). For example, at 1 min, FEN1 at 5 nM resulted in 10% of DNA
flap cleavage products but little RNA cleavage product. At 5 min, FEN1 generated
30% of DNA flap cleavage products but only 5% of RNA cleavage products. At 15
min, FEN1 produced 50% of DNA flap cleavage products and 10% of RNA
cleavage products (Fig. 3.6). The results indicate that FEN1 cleaved the 5’-DNA
flaps much faster than the RNA suggesting that FEN1 cleaved the 5’-DNA flap first
and then removed the RNA during BER in the R-loop.
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Figure 3.5 FEN1 cleavage of RNA on R-loops through BER. The ability of FEN1
cleavage on RNA on R-loops was examine by titrating increase concentrations of FEN1
on R-loop and R-loop intermediate substrate. 25 nM of 5’ 32P label RNA substrate was
incubated at 37 °C for 15 min. (A) R-loop substrate was cleaved by using 50 nM APE1
to generate the strand break. The activity of FEN1 on RNA was measured by using
increasing concentration of FEN1 (1 nM-25 nM). Lane 1 represents substrate only. Lane
2 represents APE1 cleavage of R-loops. Lanes 3-6 represents increasing concentration
of FEN1. (B) R-loop intermediate substrate was used to measure the cleavage of RNA
by FEN1 (0.1-25 nM). Lane 1 represents substrate only. Lanes 2-6 represents increasing
concentration of FEN1. Substrates and products were separated in a 15% ureadenaturing polyacrylamide gel and detected by phosphorimager. All experiments were
done in triplicates.
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Figure 3.6 FEN1 rate of cleavage between flap and RNA R-loops intermediate. The
comparison between the rate of FEN1 in cleaving 5’ DNA flaps and RNA was examined
by labeling the upstream DNA flap and the RNA on the R-loop intermediate and incubating
them with 5 nM FEN1 with increasing incubation time at 37 °C. Blue line represents the
rate of FEN1 cleavage on the 5’ DNA flap of the R-loop intermediate. Red line represents
the rate of FEN1 cleavage of the RNA on the R-loop intermediate. All experiments were
performed in triplicates.

APE1 3’-5’ exonuclease cleaves RNA during BER in an R-loop
As one of the key BER enzymes, APE1 can incise the 5’-end of an abasic
site using its endonucleolytic cleavage activity creating a 1 nt-gap as the substrate
for pol β to fill in [73]. APE1 also possesses a 3’-5’ exonuclease activity [73] that
can remove a mismatched nucleotide at the 3’-end of the upstream strand of a
one-nucleotide gap [209]. APE1 can also make endo- and exonucleolytic cleavage
on RNA [210-212]. Thus, we reasoned that APE1 can also cleave the RNA in an
R-loop during BER. To test this, we examined the APE1 cleavage activity on the
RNA of the double-flap substrate with a 36 nt-RNA and the 3’-flap substrates with
the RNA that mimics an intermediate with its 5’-flap precleaved by FEN1 (Fig. 3.7).
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We found that APE1 at 100 nM used its 3’-5’ exonuclease removed 1 and 2
ribonucleotides from the 3’-end of the RNA strand on the double-flap substrate
(Fig. 7A, lane 6). APE1 at the concentrations lower than 100 nM failed to make
any cleavage on the RNA (Fig. 3.7A, lanes 2-5). However, we found that APE1
exonuclease made an efficient cleavage on ribonucleotides from the 3’-end of the
RNA on the substrate containing a 3’-flap (Fig. 3.7B). The results indicate that
APE1 3’-5’-exonuclease progressively cleaved the ribonucleotides from the 3’-end
of the RNA in an R-loop during BER, and APE1 cleavage of the RNA on the Rloop was stimulated by the removal of the downstream 5’-DNA flap. This suggests
that APE1 cleaved the RNA after FEN1 removes the 5’-DNA flaps. To further test
this possibility, we compared the APE1 exoribonuclease activity on the RNA in the
double-flap substrate with its exoribonuclease activity on the RNA in the substrate
with a 3’-flap at various time intervals (Fig. 3.8). We found that APE1 exhibited
inefficient 3’-5’ exoribonuclease activity on the RNA strand on the double flap
substrate and only produced 10% cleavage products in 60 min (Fig. 3.8, red line).
APE1 exoribonuclease efficiently cleaved the RNA in the substrate with the 5’-flap
removed (Fig. 3.8, blue line). This further indicates that APE1 3’-5’
exoribonuclease cleavage of the RNA on an R-loop is dependent on the removal
of the 5’-DNA flaps by FEN1 suggesting the coordination between FEN1 DNA flap
cleavage activity and APE1 exoribonuclease in processing the RNA during BER in
an R-loop.
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Figure 3.7 APE1 cleavage of RNA on R-loops intermediates through BER. The ability
of APE1 cleavage on RNA on R-loops was examine by titrating increase concentrations of
APE1 on R-loop intermediates and R-loop intermediate without a 5’ flap substrate. 25 nM
of 5’ 32P label RNA substrate was incubated at 37 °C for 15 min. (A) The activity of APE1
cleavage of RNA mas measured by using increasing concentration of APE1 (5 nM-100
nM) on the R-loop intermediate. Lane 1 represents substrate only. Lane 2-6 represents
increasing concentration of APE1. (B) The activity of APE1 cleavage of RNA mas
measured by using increasing concentration of APE1 (5 nM-100 nM) on the R-loop
intermediate without a 5’ flap. Lane 1 represents substrate only. Lane 2-6 represents
increasing concentration of APE1. Substrates and products were separated in a 15% ureadenaturing polyacrylamide gel and detected by phosphorimager. The results show that
APE1 can efficiently cleave RNA when the upstream strand has been removed. All
experiments were done in triplicates.
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Figure 3.8 APE1 rate of cleavage of RNA on R-loops. The comparison between the
rate of APE1 to cleave on RNA on R-loop intermediate with and without a 5’ flap was
examined by labeling the RNA with 32P and incubating them with 25 nM APE1 with
increasing incubation time at 37 °C. Blue line represents the rate of APE1 cleavage on
the R-loop intermediate substrate without the 5’ flap. Red line represents the rate of
APE1 cleavage of the RNA on the R-loop intermediate containing a 5’ flap. The results
show that the upstream flap on R-loop intermediate block APE1 cleavage on RNA. All
experiments were performed in triplicates.

FEN1 and APE1 cleavage of RNA facilitates BER in an R-loop
To further determine if FEN1 and APE1 cleavage on RNA can facilitate BER
leading to the resolution of an R-loop, we reconstituted BER on the R-loop
substrates in the increasing concentrations of FEN1 or APE1 (Fig. 3.9). We found
that increasing concentrations of FEN1 (1 nM-25 nM) led to the increasing amount
of BER repaired product with the presence of 5 nM pol β, 10 nM LIG I with or
without 50 nM APE1 (Fig. 3.9A and 3.9B, lanes 4-7). Increasing concentrations of
APE1 (5 nM-50 nM) in the presence of 25 nM FEN1 led to a small increase of BER
repaired product (Fig. 3.9C, lanes 4-7). The results indicate that FEN1 and APE1
cleavage of the RNA in an R-loop facilitated BER leading to the resolution of the
R-loop.
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Figure 3.9 FEN1 and APE1 promotes the resolution of R-loops during BER. The
role of FEN1 and APE1 in resolving R-loop accumulation through BER was determined
by reconstituting BER on 25 nM of R-loop and R-loop intermediate incubated at 37 °C
for 30 min. (A) BER reconstitution on R-loop containing a THF as a damage. Lane 1
represents substrate only. Lane 2 represents APE1 cleavage on R-loop. Lane 3-7 shows
the effect of FEN1 at increased concentrations to promote the resolution of the R-loop
and repair of the lesion. (B) BER reconstitution in the absence of APE1 on an R-loop
intermediate. Lane 1 represents substrate only. Lane 2 represents pol β synthesis. Lanes
3-7 shows the effect of FEN1 at increasing concentrations to promote the repair of the
damage and R-loop removal. (C) BER reconstitution on R-loop intermediate with
increasing concentration of APE1. Lane 1 represents substrate only. Lane 2 shows pol
β synthesis in the presence of FEN1. Lane 3 shows repaired products of FEN1, pol β,
and LIG I. Lanes 4-7 shows repaired products during BER in the presence of increasing
concentration of APE1. Substrates and products were separated in a 15% ureadenaturing polyacrylamide gel and detected by phosphorimager. All experiments were
performed in triplicates.

DISCUSSIONS
In this study, we characterized FEN1 flap cleavage on the RNA produced
in the DNA lagging strand and R-loop. We further determined the cleavage of RNA
by both FEN1 and APE1 during BER in an R-loop and its effect on the resolution
of the R-loop. We found that human and yeast FEN1 endonucleolytically cleaved
a nicked RNA and an RNA flap attached to an RNA or DNA strand efficiently (Fig.
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3.1 and 3.2). We further demonstrated that FEN1 removed an RNA flap and
subsequently tracked down to the DNA strand and made endonucleolytic cleavage
(Fig. 3.3). We then discovered that FEN1 was recruited to R-loops in normal
human fibroblasts, and senataxin-deficient fibroblasts upon oxidative DNA
damage, 8-oxoG induced by KBrO3 (Fig. 3.4). Further analysis on FEN1 cleavage
on the RNA during BER in an R-loop showed that FEN1 cleaved the downstream
5’-DNA flap and then endonucleolytically cleaved the RNA strand (Fig. 3.5 and
3.6). Moreover, we found that APE1 exhibited an efficient 3’-5’ exoribonuclease
activity to cleave the RNA strand in an R-loop from its 3’-end through the
coordination with FEN1 cleavage of the downstream 5’-DNA flap (Fig. 3.7 and 3.8).
We showed that the RNA cleavage activity of FEN1 and APE1 during BER in an
R-loop facilitated the production of the BER repaired product (Fig. 3.9). Our results
supported a model during which oxidative stress induces oxidative DNA damage
such as 8-oxoGs on the non-template strand of an R-loop. 8-oxoG DNA
glycosylase 1 (OGG1) removes 8-oxoGs and generates abasic sites on the nontemplate strand. APE1 incises the AP sites and the loop converting the R-loop into
a double-flap intermediate with a RNA:DNA hybrid. FEN1 removes the
downstream 5’-DNA flap leaving an intermediate with a 3’-DNA flap and an
RNA:DNA hybrid. Subsequently, FEN1 uses its endonucleolytic cleavage activity
to remove the RNA from its 5’-end, whereas APE1 uses its 3’-5’ exoribonuclease
activity to remove the RNA from its 3’-end. The removal of the RNA leaves a DNA
gap, which is filled by pol β DNA synthesis. Finally, LIG I seals the nick generated
by pol β DNA synthesis (Fig. 10).
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Figure 3.10 A hypothetical of R-loops mitigation by BER. R-loops accumulation can be
mitigated by BER through oxidative DNA damage which targets the single stranded region
of the R-loop. The damage base is removed by a damage specific DNA glycosylase leaving
an abasic site that is incised by APE1 at the 5’-end to generate the strand break.
Subsequently, the APE1 cleavage generates R-loop intermediate containing a double flap.
The 5’ downstream flap will be removed by FEN1 to allow the access of APE1 cleavage 3’
to 5’ of the RNA and FEN1 will cleave 5’ to 3’ of the RNA. The removal of the RNA will
facilitate the reannealing of the upstream strand and pol β and LIG I will complete the repair
of the damage. Thereby, leading to the resolution of the R-loop.
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Since the Bambara group has reported that calf thymus FEN1 can cleave
an RNA flap [202] indicating that mammalian FEN1 also possesses a ribonuclease
activity, the work by Stevens also has shown that human FEN1 can
endonucleolytically cleave mRNA and rRNA at the junction of RNA flaps, RNA
hairpins, and bubbles [203]. A recent study implicates that FEN1 is involved in
processing RNA:DNA hybrid to prevent telomere fragility during DNA leading
strand synthesis [193] suggesting a role of FEN1 in processing RNA in telomeres.
However, the mechanisms and function of FEN1 ribonuclease activity and its
coordination with DNA flap cleavage activity remains unknown. Here we provide
the first evidence that both human and yeast FEN1 use their ribonuclease activity
to cleave RNA endonucleolytically (Fig. 3.1 and 3.2). Interestingly, we found that
FEN1 removed an RNA flap efficiently and then tracked down to the junction
between the RNA and DNA or the DNA region to make an endonucleolytic
cleavage (Fig. 3.1 and 3.3) indicating that FEN1 preferentially makes a cleavage
on DNA. Furthermore, for the first time we demonstrated that FEN1 RNA cleavage
activity was employed to process the RNA strand during BER of an R-loop in
human cells (Fig. 3.4 and 3.6). We showed that FEN1 5’-endoribonuclease
coordinated with APE1 3’-5’ exoribonuclease to remove the RNA strand in an Rloop during BER of a base lesion on the non-template strand facilitating BER and
leading the resolution of the R-loop (Fig. 3.7 and 3.9). Our results indicate that
FEN1 employs a unique mechanism to cleave RNAs leading to resolution of Rloops through BER. The roles of FEN1 in RNA metabolism and miRNA biogenesis
and genome maintenance need to be elucidated in the future.
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The cleavage of RNA by APE1 was first identified by the Hickson group in
the 1990s [210]. Later studies have shown that APE1 endoribonuclease can incise
the 5’-end of an abasic site in mRNAs and RNA at a site-specific manner leading
to their removal [213, 214]. In this study, for the first time, we found that APE1 3’5’ exoribonuclease but not endoribonuclease activity progressively cleaved the
RNA strand during BER in an R-loop (Fig. 3.7 and 3.8). We showed that the
exoribonuclease activity of APE1 was dependent on the removal of the
downstream 5’-DNA flap by FEN1 (Fig. 3.7 and 3.8), demonstrating functional
coordination between the two BER enzymes in removing the RNA strand during
BER in an R-loop. It is possible that the 5’-DNA flap in the double-flap intermediate
formed during BER in an R-loop inhibited the binding of APE1 to the 3’-end of the
RNA strand, thereby preventing the enzyme from making a ribonucleotide
cleavage.
Our study further indicates that BER can serve as a new pathway to resolve
R-loops through FEN1 endonucleolytic cleavage of DNA and RNA flaps and its
coordination with APE1 3’-5’ exoribonuclease cleavage of the RNA strand (Fig.
3.10). It appears that the non-template strand of an R-loop forms hotspots of
oxidative DNA damage such as 8-oxoGs that are subsequently repaired by BER.
This, in turn, results in the ssDNA breaks on the non-template strand leading to
the opening of the R-loop converting it into a double-flap intermediate with an
RNA:DNA hybrid that can be further processed by FEN1 DNA flap cleavage and
endoribonuclease activity along with APE1 3’-5’ exoribonuclease activity. It has
been shown that other BER enzymes and cofactors, including OGG1 and NEIL2
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DNA glycosylases, X-ray repair cross-complementing protein 1 (XRCC1), and
poly(ADP-ribose) polymerase 1 (PARP1) are also involved in RNA metabolism and
quality control. Thus, it is conceivable that these BER enzymes and cofactors can
cooperate with FEN1 and APE1, leading to the efficient removal of the RNA during
BER in R-loops. The molecular mechanisms underlying the resolution of R-loops
through the BER pathway remains to be elucidated.
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